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ABSTRACT 
Tania Alejandra Desrosiers.  Maternal occupational exposure to organic solvents  
during early pregnancy and selected congenital anomalies 
(Under the direction of Andrew F. Olshan, Ph.D.) 
 
 
Background: As more women enter the labor force, there is increased epidemiologic 
interest in the possible effects of employment and occupational exposures on adverse 
pregnancy outcomes.  Using data from the National Birth Defects Prevention Study, we 
examined the prevalence and patterns of maternal employment before and during pregnancy, 
and examined the relation between maternal occupational exposure to organic solvents 
during the periconceptional period (first trimester and month before conception) and neural 
tube defects (NTDs) and orofacial clefts (OFCs), which toxicological data suggest may be 
susceptible to oxidative stressors like solvents.   
Methods: Cases of NTDs (anencephaly; spina bifida; encephalocele) and OFCs (cleft 
lip ± cleft palate; cleft palate) delivered between 1997 and 2002 were identified by birth 
defect surveillance registries in 8 states; non-malformed control infants were selected using 
birth certificates or hospital records.  Exposure to aromatic, chlorinated and Stoddard 
solvents were estimated by industrial hygienist review of self-reported occupational histories 
in combination with a literature-derived exposure database.  We used employment dates to 
examine variability in employment status and estimated exposure prevalence to any solvent 
across different time periods before and during pregnancy among controls.  Odds ratios (OR) 
and 95% confidence intervals (CI) for the association between solvent class and each birth 
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defect group and component phenotype were estimated using logistic regression, adjusting 
for maternal age, race/ethnicity, education, pre-pregnancy body mass index, folic acid 
supplement use and smoking.   
Results: Over 70% of mothers worked at some point 3 months before and during 
pregnancy; employment status was not constant throughout pregnancy for 25% of these 
women.  The prevalence of estimated exposure to any solvent during the periconceptional 
period among mothers of NTD cases (n=511), OFC cases (n=1163) and controls (n=2997) 
was 13.1%, 9.6% and 8.2%, respectively.  No solvent class was associated with OFCs in 
these data.  Exposure to chlorinated solvents was associated with increased odds of NTDs 
(OR=1.96; CI=1.34, 2.87), particularly spina bifida (OR=2.26; CI=1.44, 3.53).     
Conclusions: Future studies of maternal employment should focus on the biologically 
relevant critical exposure window to reduce misclassification.  Maternal occupational 
exposure to chlorinated solvents during early pregnancy may be associated with NTDs and 
merits further research.   
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 CHAPTER 1: BACKGROUND 
1.1  Organic solvents 
Organic solvents are a group of liquid, hydrocarbon-based chemicals able to extract, 
dissolve, or suspend fats, oils, and waxes.  They are commonly used in industrial, 
commercial, and household settings as a cleaner, degreaser, chemical thinner or dissolver, 
and as an intermediate or reagent during synthesis of other chemicals.  They are also a major 
component of paints and paint thinners, stripping agents, dry cleaning solutions, printing 
inks, dyes, adhesives, pesticides, and gasoline.  Solvents are most often used in mixtures; 
hundreds make up over 30,000 industrial solvent formulations.1     
Organic solvents are classified into subgroups primarily by molecular structure or 
functional group, including aliphatic, alicyclic, aromatic, and halogenated (e.g. chlorinated) 
hydrocarbons, as well as alcohols, ketones, aldehydes, esters, petroleum distillates, and 
glycol ethers.  This dissertation research focuses on six chlorinated hydrocarbons (carbon 
tetrachloride, chloroform, methylene chloride, perchloroethylene, trichloroethylene, 1,1,1-
trichloroethane), three aromatic hydrocarbons (benzene, toluene, xylene), and a petroleum 
mixture known as Stoddard solvent.   
1.1.1  Human exposure 
Most people experience low-level exposure to solvents on a daily basis while using 
household cleaners or glue, painting, going to the dry cleaners, or filling their car at a 
gasoline station.  Higher doses are delivered by cigarette smoking or exposure to 
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environmental tobacco smoke.  Some organic solvents are also common air pollutants (e.g. 
benzene) and drinking water contaminants (e.g. trichloroethylene).  Another source of 
exposure is intentional solvent abuse (known as “huffing”), which is increasing in 
prevalence.2  Occupational exposure, however, is among the most important exposure 
sources to consider for two reasons: first, solvents are exceedingly common in the workplace 
across multiple industries; and second, exposure levels in the occupational setting are usually 
substantially higher than those encountered during casual daily exposure.  Occupations 
commonly exposed to organic solvent mixtures include painters, artists, laboratory workers, 
mechanics and machinists, tile setters, plumbers and carpenters, shoe and leather production 
and repair workers, photographic processing workers, dry cleaning workers, those who work 
with glues, some cosmetologists and hairdressers, and chemical manufacturing and 
petroleum workers.3-12  For many occupations, exposure concentrations in the air as well as 
in workers’ blood are well-characterized using personal air sampling and biomonitoring.  
Table 1 summarizes common industrial applications and occupations with potential exposure 
to each of the 10 organic solvents of interest in this dissertation.   
The Occupational Health and Safety Administration (OSHA) estimates that 10 
million people are exposed to organic solvents in the workplace.13  The most recent national 
data for women specifically come from the National Occupational Exposure Survey 
conducted in the early 1980’s which estimated that approximately 400,000 women were 
exposed to toluene; 800,000 to trichlorethane; 400,000 to xylene; 150,000 to benzene; and 
230,000 to Stoddard solvent;12,13 these estimates are thought to underestimate current 
exposure prevalence since participation of women of reproductive age and mothers with 
young children in the paid labor force has steadily increased over recent decades.14  Two 
 3
thirds of mothers age 15 to 64 years with a first birth between 2001 and 2003 worked for pay 
during pregnancy, up from approximately 44 percent among those with a first birth between 
1961 and 1965.15  
The exact proportion of women in the United States or elsewhere who are 
occupationally exposed to any organic solvent during pregnancy is unknown.  In recent 
population-based case-control studies of maternal occupational exposure and birth defects, 
estimated exposure prevalence to any organic solvent at different points throughout 
pregnancy ranged widely from zero to nearly 40 percent among controls (Section 1.4).  
Approximately 4 percent of controls in a case-control study of fetal death in California self-
reported occupational exposure to solvents or degreasers at some point during pregnancy; 
women reported a higher exposure prevalence in the first trimester (2.8%) compared to 
subsequent trimesters (2.0% and 1.2% in 2nd and 3rd trimesters, respectively).16   
1.1.2  General toxicity 
Given that organic solvents share many physical and chemical properties, their 
toxicity profiles are often described collectively.  However, mechanisms of toxicity are 
thought to differ to some degree between agents and more information is known about some 
organic solvents than others.  In the following sections, we describe solvent toxicity in 
general terms with attention to important known differences between solvent classes or 
individual solvents.   
Organic solvents are volatile and lipophilic, which together with small molecular size 
and lack of charge contribute directly to their enhanced ability to be absorbed into the body.  
Inhalation is the most common route of exposure in humans using solvents at home or work, 
though dermal and oral absorption following direct contact is also possible.  Once inhaled, 
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organic solvents are readily absorbed across the alveolar-capillary membrane in the lung and 
are then widely distributed throughout the body.  These chemicals subsequently concentrate 
in lipid-rich tissues such as the brain (this accounts for observed central nervous system 
effects following acute exposure).  Multiple metabolic pathways are involved in 
detoxification and also bioactivation depending on the specific solvent and route of exposure.  
In general, organic solvents are rapidly metabolized and excreted, and do not tend to persist 
in the body more than a few days after exposure ceases.  However, constant exposure at any 
level results in a measurable body burden during the exposed time period and shortly 
thereafter.17   
Health effects associated with organic solvent exposure have been investigated in 
both animal and epidemiological studies.  In general, long-term exposure to organic solvents 
is thought to be neurotoxic, hepatotoxic, hematotoxic, and potentially carcinogenic.  Acute 
effects following short-term exposure include fatigue, concentration disorder, dizziness, 
headache, and vomiting.  Exposure to higher doses, such as those experienced during 
intentional solvent abuse, result in euphoria, delusions, hallucination, loss of consciousness 
and death.13   
The various mechanisms by which organic solvents exert toxicity are unclear and 
assumed to vary from one solvent to another.  Further, the toxicity of solvents within the 
same class can vary, whereby subtle differences in chemical structure translate into 
significant differences in toxicity.  For example, halogenated hydrocarbons are known to be 
mutagenic by generating free radicals, while aromatic hydrocarbons seem to disrupt 
polyribosomes.13  Other solvents are also thought to damage lipid membranes through lipid 
peroxidation.18  In some cases, a solvent exhibits toxicity in its primary form; in other cases, 
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metabolites formed during activation of certain detoxification pathways have more potential 
to cause harm (e.g. trichloroacetic and dichloroacetic acids, the metabolites of 
trichloroethylene and perchloroethylene).  Adding further complexity is the fact that most 
solvent exposures involve multiple chemicals, and less is known about the toxicity of solvent 
mixtures relative to individual compounds.  The toxic effects of multiple solvents are often 
assumed to be additive, though solvents may also interact synergistically or antagonistically.  
For example, repetitive alcohol consumption induces the P450 enzyme system, which may 
subsequently result in metabolic activation of other solvents to cytotoxic metabolites.13  
Concurrent exposure to benzene and toluene is thought to reduce the genotoxicity and 
erythropoietic toxicity caused by benzene exposure alone.19   
1.1.3  Developmental toxicity 
A fundamental principle of teratology is that developmental toxicity may be 
manifested in several ways: embryonic or fetal death, malformation, growth retardation, or 
functional deficit.20,21  For some compounds, these four endpoints correspond to a continuum 
of increasing toxicity whereby low doses cause growth restriction and higher doses cause 
malformations or death.  However, any given compound can produce one outcome and not 
another under certain conditions and the primary outcome can change depending on the 
animal species or strain.  It is often the case that concordant defects are not induced by the 
same teratogen in laboratory animals and humans,17 though it has been demonstrated that 
humans may sometimes be up to 10 times more sensitive than lab animals to known 
teratogens given optimal conditions.20  Therefore, an indication of developmental toxicity in 
animal models points to a possible effect in humans that warrants further investigation.  
Approximately one third of solvents tested for teratogenicity in animal models have been 
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positive,13 though only ethanol and toluene (at high doses) are considered known human 
teratogens.22  Of the 10 organic solvents included in this research project, all have been 
investigated with varying intensity with regard to developmental toxicity.  Most exhibit 
teratogenic and fetotoxic effects (less evidence for methylene chloride and Stoddard solvent), 
and the developing nervous system appears to be a particularly sensitive target for specific 
compounds including xylene, toluene and perchloroethylene.1,3-13,17 
In humans, there is not much information on the toxicity of organic solvents in-utero, 
though it is known that organic solvents cross the placental barrier.  Changes in maternal 
toxicology during pregnancy, such as enhanced blood flow to the lungs and increased cardiac 
output, improve absorption of organic solvents after inhalation exposure.1  Further, an 
increase in body fat during pregnancy allows for a higher body burden of solvents and 
reduces elimination time.13  Factors related to the placental-fetal compartment also play a 
role in the absorption of these compounds. Approximately half of the fetal blood circulation 
reaches the fetal heart and brain directly,18 and organic solvents are known to concentrate in 
the lipid-rich brain.  Fetal capacity to “store” solvents may thus effectively increase the 
maternal-fetal body burden.  Perchloroethylene, for example, has been shown to accumulate 
in the fetus at concentrations higher than those measured in the mother.6  Since fetal 
metabolic pathways for most solvents do not exist, metabolism is conducted primarily by 
maternal systems.2   
The specific mechanisms of teratogenesis by which organic solvents exert 
developmental toxicity are not well understood.  A leading hypothesis is that these 
compounds create reactive oxygen species (ROS) and subsequently produce oxidative stress 
(OS) to which early embryonic development is strongly susceptible.23-26  The role of OS in 
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best described for ethanol-induced toxicity, though the literature is growing on other organic 
solvents.  Animal models suggest that alcohol exposure during early gestation decreases 
neural crest cell proliferation and promotes excessive cell death, leading to facial and brain 
abnormalities as well as reductions in certain antioxidant enzyme activity.27,28  In general, 
oxidant-induced or redox misregulation of cellular components responsible for 
developmental signals may result in a decrease in cell proliferation, alter cytodifferentiation, 
or promote apoptosis.  The effects of generalized OS on multiple specific signal transduction 
pathways leading to teratogenesis has been recently described in the literature.24  Early 
organogenesis is identified as a particularly sensitive time period to changes in the redox 
environment since antioxidant defenses are still immature,24 though OS could pose a 
significant threat to normal growth and development throughout gestation since oxidation 
diminishes the capacity of fetal tissues to biotransform xenobiotics.26  Antioxidants have 
been shown to ameliorate the effects of excessive cell death in selected cell populations and 
subsequent malformations associated with exposure to teratogenic concentrations of 
ethanol.28,29 
Several pharmaceuticals, pesticides, metals, and environmental contaminants are 
capable of generating ROS and subsequently inducing OS.24,25,30   The capacity of a number 
of organic solvents to induce the ROS-OS mechanism has been documented, including 
carbon tetrachloride, chloroform, methylene chloride, trichloroethylene, perchloroethylene, 
and benzene.24,30,31  There is also some evidence that neural tissue may be particularly 
vulnerable to oxidative stress caused by solvents.   Following exposure, the early expression 
of CYP2E1 (a mixed function oxidase pathway primarily involved in the metabolism of 
some organic solvents) in the fetal brain suggests that this tissue may be particularly 
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vulnerable to OS as a result of solvent metabolism.7  Several other factors, including a high 
rate of oxygen consumption, contribute to the unique sensitivity of CNS cells to OS.30  The 
role of ROS in the targeted cytoxicity of neural crest cells following ethanol exposure is also 
well-documented and supports the hypothesis that solvents as a chemical class may exert 
preferential toxicity on the developing central nervous system.   
The body of literature investigating the association between maternal solvent 
exposure and various reproductive and developmental outcomes in humans is slowly 
growing.  Several adverse outcomes have been considered, including infertility and delayed 
conception, spontaneous abortion, preeclampsia, preterm birth, growth retardation, 
congenital malformation, and developmental delay.3-13,17,32  Intentional solvent abuse has also 
been studied and is known to cause a spectrum of defects and developmental abnormalities 
known as Fetal Solvent Syndrome, which resembles the well-documented Fetal Alcohol 
Syndrome caused by alcohol consumption during early pregnancy.  With a growing yet 
inconsistent body of evidence from experimental studies of animal models indicating that 
organic solvents exert developmental toxicity, these compounds can be reasonably expected 
to have the capacity to induce congenital malformations under certain conditions in humans 
as well.   
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Table 1.  Description of the 10 organic solvents of interest in this dissertation 
Solvent (CAS)  
   synonyms 
Common industrial uses Primarily exposed occupations  OSHA PEL 
(ppm) 
CHLORINATED SOLVENTS 
   carbon tetrachloride (56-23-5) 
carbona, carbon chloride, 
carbon tt,  benzinoform, 
methane tetrachloride, 
perchloromethane, 
tetrachloromethane  
Used in manufacturing of: 
   refrigerants 
   aerosol propellants 
Chemical manufacturing workers 10 
   chloroform (67-66-3) 
trichloromethane, 
methyltrichloride 
Used in manufacturing of:  
   fluorocarbons and refrigerants 
   aerosol propellants 
   plastics 
   paper products 
Purification of antibiotics 
Photographic processing 
Dry cleaning agent 
Research chemistry 
Water treatment plant workers 
Paper and pulp mill workers 
Waste management and incineration workers 
Pool or spa workers (including lifeguards and  
   swimming coaches) 
50 
   methylene chloride (75-09-2) 
dichloromethane, methylene 
dichloride, methylene bichloride 
Used in manufacturing of: 
   pharmaceuticals 
   photographic film 
   aerosol propellants 
Component of paint remover and floor stripping 
   solution, spray paint, and automotive cleaner 
Painters and paint industry workers 
Aerosol packing workers 
Metal cleaners 
25 
 
 
   perchloroethylene (127-18-4) 
PERC, tetrachloroethylene, 
ethylene tetra-chlorid, pert, 
perclene, perchlor 
Dry cleaning agent 
Degreasing agent 
Component of water repellent, silicone lubricant,   
   fabric finisher, spot remover, adhesives, wood  
   cleaner, printing ink, and rust removers 
Used as a textile-processing solvent 
Dry clearners 
Metal cleaners 
100 
   trichloroethylene (79-01-6) 
TCE, 1,1,2-trichloroethylene, 
trichloroethene, 1,1-dicloro-2- 
chloroethylene, acetylene 
trichloride, ethylene trichloride 
Dry cleaning agent 
Degreasing agent 
Intermediate in chemical synthesis of other agents  
   including organic solvents 
Component of adhesives, and lubricants 
Component of consumer cleaning agents including  
   strippers, stain removers and rug-cleaning fluids 
Degreasing operation workers 
Wood processing workers 
Plastics manufacturing workers 
Gas furnace operators and repair workers 
Laboratory technicians 
100 
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   1,1,1-trichloroethane (71-55-6) 
TRI, methyl chloroform,1,1,1-
TCE,  α-trichloroethane, 
chloroethane 
Common industrial solvent found in consumer  
   degreasing and cleaning agents 
Component of adhesives, aerosol sprays, and paint 
Used in microelectronics industry 
Currently, there are no highly exposed occupations 
because domestic production and use was phased out 
(effective 2002).  Since 2005, no 1,1,1-trichloroethane 
was used in the U.S.   
350 
AROMATIC HYDROCARBONS 
   benzene (71-43-2) 
benzyl,benzol, cyclohexatriene 
Used in manufacture of: 
   detergents 
   pesticides 
   other solvents 
   paint removers 
   rubber 
   lubricants 
   dyes 
Component of gasoline 
Intermediate in chemical synthesis of other agents  
   including styrene  
Benzene production, storage, and transport workers     
   (especially in petrochemical, petroleum refining,      
   coke, coal, and chemical manufacturing industries) 
Rubber tire manufacturing workers 
Printing workers 
Rubber workers 
Shoe makers 
Laboratory technicians 
Firefighters 
Gasoline station employees 
Janitors and dry cleaning workers 
1 
   toluene (108-88-3)  
toluol, methylbenzene 
Used in manufacture of: 
   benzene 
   rubber 
Component of paints, inks, dyes, lacquers,     
   fingernail polish, adhesives, and gasoline 
Used in the printing and leather tanning industries 
Painters and paint industry workers 
Artists and printing workers 
Petroleum, fuel, and gasoline station workers 
Floor and carpet installation workers 
Automotive workers 
Cosmetologists 
200 
   xylene (1330-20-7)  
Xylol, dimethylbenzene 
Used in manufacture of: 
   other organic solvents 
   plastic and rubber 
   leather and shoes 
   coated fabric and paper 
Component of paints, wood finishers, and gasoline 
Carrier for insecticide application 
Used in the printing industry 
Painters and paint industry workers 
Biomedical laboratory workers 
Wood processing plant workers 
Automobile garage workers 
Metal workers 
Furniture refinishers 
100 
 
PETROLEUM DISTILLATE    
Stoddard solvent (8052-41-3) 
dry cleaning safety solvent, 
naphtha safety solvent,  
petroleum solvent, PD-680, 
varnoline, spotting naphtha 
Component of paint thinner, photocopier toner,  
   printing ink, and adhesives 
Used as a dry cleaning solvent  
Used as a general cleaner/degreaser for engine  
   parts in machine and automotive repair shops 
Janitors and dry cleaning workers 
Printing workers 
500 
CAS: A unique chemical identification number designated in the Chemical Abstracts Services database. 
OSHA PEL: “Permissible exposure limit,” enforceable maximum concentration in workroom air allowable during an 8-hr workday in a 40-hr workweek. 
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1.2  Epidemiology of neural tube defects 
This section provides a brief review of the epidemiology of neural tube defects, 
including etiology and classification, prevalence, risk factors and public health impact. 
1.2.1  Etiology and classification of NTDs 
Neural tube defects are a group of heterogeneous congenital anomalies affecting the 
central nervous system that result from failure of the neural tube to close at either the cranial 
or caudal neuropore during the fourth week of embryogenesis.  Though primary closure is 
usually implicated, clinical and experimental evidence support the rare possibility that a 
closed neural tube can subsequently re-open under certain conditions.33  During normal 
embryonic development, closure of the anterior (i.e. cranial) neuropore occurs on the 26th 
day of gestation and closure of the posterior (i.e. caudal) neuropore occurs on the 28th day.  
Defects resulting from secondary re-opening of the neural tube are thought to occur over an 
extended period of time later in development.   
Neural tube defects affect either the spine or cranium, and are classified as open when 
neural tissue is exposed (open NTDs often involve both the spine and cranium) or closed 
when neural tissue is not exposed (closed NTDs usually affect the spine only).33  Cranial 
NTDs include anencephaly and encephalocele.  Anencephaly is a lethal defect defined by the 
absence of a large part of the brain, skull, and scalp due to failure of the cephalic portion of 
the neural tube to close.  Spina bifida is the primary group of malformations of the spinal 
cord, and is defined by incomplete closure of the neural tube along the spinal column, 
typically in the lumbar region.   
In epidemiologic investigations, NTDs are commonly grouped together and studied 
as one outcome to improve sample size.  Although NTDs occur as a result of similar 
 12
embryologic processes, there is sufficient epidemiologic and biologic evidence supporting 
their etiologic heterogeneity.34-36  For example, some teratogens are strongly associated with 
spina bifida but not anencephaly.  These findings imply that defects of the brain and spinal 
cord should be considered individually when methodologically feasible.   
1.2.2  Prevalence of NTDs 
Neural tube defects are relatively common birth defects, affecting approximately one 
in 1000 pregnancies in the United States.37  The true incidence of NTDs is difficult to 
estimate, since many cases do not progress to live birth.  At least one third of all known cases 
of NTDs end in spontaneous or elective abortion.35  However, the proportion of terminated 
pregnancies varies by geographic location, type of NTD, and gestational age at prenatal 
diagnosis.38,39  In a study of 6 state surveillance programs from 1985 to 1994, between 10 and 
40 percent of prenatally diagnosed cases were electively terminated.38  Estimates in Europe 
are substantially higher.40  Cases of anencephaly are more likely to be terminated than cases 
of spina bifida.   
The fact that methods for case identification and ascertainment vary across 
surveillance programs complicates the estimation of national birth defect rates.  Active 
surveillance programs usually yield more cases than passive systems, as do programs that 
seek cases among fetal deaths and electively terminated pregnancies.  In 2007, population-
based surveillance data for 45 specific defects from 32 states were published.  However, 
differences in surveillance methodology precluded calculation of prevalence estimates for all 
states combined.41  The National Birth Defects Prevention Network (NBDPN) published 
national estimates of select birth defects using pooled data from active population-based 
surveillance programs in 11 states from 1999 to 2001; this sample is thought to represent 22 
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percent of U.S. live births.42  All of the surveillance programs included fetal deaths; all but 
one included elective abortions.43  Table 2 presents the estimated prevalence of NTDs for 
births of all race/ethnicity.  Note that the numerator of the estimates includes known cases 
among live births, fetal deaths and elected abortions, and the denominator includes live births 
only.   
 
Table 2.  Estimated prevalence of NTDs among U.S. births, 1999-2001, NBDPN. 
Defect Estimated prevalence  
per 10,000 live births* 
(95% CI) 
Estimated annual no. 
of cases (95% CI) 
Race/ethnicity trends 
compared to non-
Hispanic whites 
Anencephalus 2.51 (2.31, 2.70) 1,009 (931 – 1,088) ↓ BL; ↑ HISP 
Spina bifida  3.68 (3.45, 3.92) 1,477 (1,383 – 1,572) ↑ HISP 
Encephalocele 0.93 (0.82, 1.05) 376 (328 – 423) ↑ BL; ↑ HISP 
* Estimates adjusted for maternal age and maternal race/ethnicity 
Abbreviations: NTD = neural tube defect; NBDPN = National Birth Defect Prevention Network; CI = confidence interval; 
BL = non-Hispanic black, HISP = Hispanic 
Source: Canfield (2006) 42 
 
These national estimates were recently updated using data from 2004-2006.44  
Though the estimated prevalence of NTDs were similar to that in 1999-2001, this updated 
analysis showed that the estimated prevalence varies significantly by type of surveillance 
system (active vs. passive with follow-up vs. passive) and pregnancy outcomes included (live 
births; stillbirths; terminations).  Active surveillance systems that include all pregnancy 
outcomes ascertained the most cases. 
As indicated in Table 2, the prevalence of NTDs varies by maternal race/ethnicity; 
infants of Hispanic origin born in the U.S. have a higher prevalence of NTDs as well at 
higher risk of mortality due to the defect than infants born to non-Hispanic white 
mothers.42,45  Geographic and temporal variation in the prevalence of NTDs is also well-
documented.34,41   
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1.2.3  Factors associated with NTDs 
It is generally accepted that most cases of NTDs have a multifactorial etiology, with a 
significant genetic component that likely interacts with a number of environmental factors.  
To date, no single gene has been implicated as a direct causal agent.  Chromosomal 
abnormalities, single gene mutations, and teratogenic causes are identified in less than 10 
percent of cases.35  Fortunately, the discovery of dietary folate as a protective factor has 
dramatically reduced the incidence of NTDs.   Maternal B-vitamin folic acid intake of at least 
0.4 mg/day before conception and during early pregnancy reduces the incidence of NTDs by 
up to 70 percent.35,37  Folic acid is the greatest known modifier of NTD risk to date.  Table 3 
presents a comprehensive list of factors known or suspected of being associated with NTDs; 
factors indicated in italics are those considered to be known risk factors. 
 
Table 3.  Factors associated with neural tube defects 
Maternal and fetal factors Environmental factors 
Alcohol use 
BMI (>29) 
Demographic factors 
   maternal age 
   maternal race/ethnicity 
Folic acid 
Hyperthermia and febrile illness 
Infant sex (female) 
Parity 
Previous history of SAB 
Previous history of NTD 
Maternal metabolic conditions1
    
Maternal infections2 
Serum glucose concentration 
   diabetes 
   hyperinsulinemia & hyperglycemia 
Smoking 
Stress 
Therapeutic drug use3 
Androgenic hormones 
Chlorination disinfection byproducts  
Fumonisin-contaminated food 
Metals 
Nitrates 
Pesticides 
Proximity to landfills 
Some industrial chemicals 
   anesthetic agents 
   organic solvents 
   paints 
   vinyl chloride 
Some occupations 
X-irradiation 
1
 Maternal infections include: cytomegalovirus, rubella, syphilis, and toxoplasmosis  
2
 Maternal metabolic conditions include diabetes, endemic cretinism, and phehylketonuria 
3
 Therapeutic drugs include anticonvulsants, antihistamines, folic acid antagonists, diuretics, and sulfonamides 
Abbreviations: BMI = body mass index; SAB = spontaneous abortion 
Sources: Cabrera (2004); Detrait (2005); Hwang (2003); Mitchell (2005); Sever (1995); 34,36,37,46,47 
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It has been recommended that the potential roles of environmental and occupational 
agents in the etiology of NTDs be more rigorously investigated.36  Human susceptibility to 
environmental teratogens may hinge on a complex interaction of genetic susceptibility, 
appropriate timing, exposure characteristics, and the availability of protective factors.37  The 
pathogenesis of NTDs is thought to involve a failure in cellular proliferation, alterations in 
the shape of the developing neuroectoderm, or abnormal changes in the supporting 
vasculature.37  These events can be caused by a number of endogenous and exogenous 
factors that alter gene expression or damage cellular activity directly.  It is possible that 
maternal exposure to organic solvents during early pregnancy could affect normal 
neurulation by altering gene expression or by inducing targeted cell death or damage.  Refer 
to Section 1.1.3 for a description of the hypothesized biologic mechanisms by which organic 
solvent exposure may be associated with an increased risk of neural tube defects.   
1.2.4  Public health impact 
Infants born with a NTD have an increased risk of death in the first year and also in 
adult years; survival rates vary by phenotype and severity.34,45,46  On average, survival among 
individuals born with spina bifida is approximately 87 percent at year one, and 78 percent by 
18 years.34  Anencephaly is uniformly lethal by the end of the first year; most affected infants 
are stillborn or die shortly after birth.35  
Depending on the severity of the defect, affected infants also suffer significant 
morbidity ranging from mild physical dysmorphology to severe physical and developmental 
disabilities requiring lifelong management.  For example, spina bifida often results in lack of 
neural function below the level of the defect and is associated with a range of negative 
sequelae including reduced ability to walk or paralysis, hydrocephalus, endocrine 
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abnormalities, deformation of the limbs or spine, learning disabilities, and bladder, bowel, 
and sexual dysfunction.35,46  In addition, approximately 20 percent of NTD-affected infants 
are diagnosed with at least one other congenital anomaly.35  The resulting physical, 
emotional and financial burden makes the reduction of these defects an important public 
health effort. 
1.3  Epidemiology of orofacial clefts 
This section provides a brief review of the epidemiology of orofacial clefts, including 
etiology and classification, prevalence, risk factors and public health impact. 
1.3.1  Etiology and classification of OFCs 
Orofacial clefts include cleft lip (CL) and cleft palate (CP) and result from incomplete 
fusion between any of the embryonic facial swellings destined to become part of the 
craniofacial area.  Orofacial development in the embryo initiates with the appearance of the 
prechordal plate at the cranial end of the embryonic disk on the 14th day of gestation, and is 
fairly complete by the 48th day when the upper jaw and lip components fuse.48  In general, 
the critical time window for OFCs is considered to be between the 6th and 10th week post-
conception, though the period of development most sensitive to teratogens is day 36 for CL 
and weeks 8 through 9 for CP.17,33  Cleft lip defects result from failure of the maxillary 
swelling to fuse with the intermaxillary process.  These defects range in length (e.g. from a 
minor notch in the vermilion border of the upper lip to a cleft that completely separates the 
lateral lip from the philtrum and nasal cavity), depth (e.g. from involving just soft tissue to 
dividing the primary palate completely), and can be unilateral or bilateral.  Cleft palate 
results from failure of the palatine shelves to fuse.  These craniofacial abnormalities often 
occur together, though they are generally considered to be etiologically distinct.  Very severe 
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cleft lip defects may induce clefting of the palate; therefore, cleft lip with and without cleft 
palate (CL/P) are often grouped together and considered distinct from isolated CP.33,49   
1.3.2  Prevalence of OFCs 
Orofacial clefts are the second most common congenital anomaly among live births.  
It is often cited that approximately one in 1,000 live births is affected with an OFC, which 
translates to 4,000 infants a year in the United States.50  More recent estimates suggest that 
one in 850 and one in 1500 births per year are affected by CL/P and CP, respectively.51,52   
As described previously in Section 1.2.2, the NBDPN recently published national population-
based prevalence estimates for select defects using data collected from active surveillance 
programs in 11 states from 1999 to 2001.42  Table 4 summarizes select results for OFCs. 
 
Table 4.  Estimated prevalence of OFCs among U.S. births, 1999-2001, NBDPN. 
Defect Estimated prevalence 
per 10,000 live births* 
(95% CI) 
Estimated annual no. 
of cases (95% CI) 
Race/ethnicity trends 
compared to non-
Hispanic whites 
CL/P 10.47 (10.08, 10.87) 4,209 (4,050 – 4,367) ↓ BL 
CP only 6.39 (6.08, 6.71) 2,567 (2,445 – 2,689) ↓ BL; ↓ HISP 
* Estimates adjusted for maternal age and maternal race/ethnicity 
Abbreviations: OFC = orofacial cleft; NBDPN = National Birth Defect Prevention Network; CL/P = cleft lip with or without 
cleft palate; CP = cleft palate; CI = confidence interval; BL = non-Hispanic black, HISP = Hispanic 
Source: Canfield (2006) 42 
 
 
These national estimates were recently updated using data from 2004-2006.44  
Though the estimated prevalence of OFCs were similar to that in 1999-2001, this updated 
analysis showed that the estimated prevalence varies slightly by type of surveillance system 
(active vs. passive with follow-up vs. passive). 
The distribution of CL/P varies by race/ethnicity, infant sex, geographic distribution, 
and demographic factors such as SES, whereas the distribution of CP is relatively uniform.53  
In general, Native Americans have the highest incidence of CL/P, followed by Asian-
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Americans, non-Hispanic whites, and Hispanics.  African-Americans have the lowest risk of 
both CL/P and CP.  Interestingly, females are more likely to have CP (sex ratio = 3:2) and 
males are more likely to have CL/P (sex ratio = 2:1) in white populations, though this pattern 
is inconsistent across different race/ethnicities.48   
1.3.3  Factors associated with OFCs 
Like NTDs, the causes of OFCs are likely multifactorial.  Though there is a strong 
pattern of familial aggregation, few modifiable risk factors are consistently and strongly 
associated with clefts other than alcohol consumption and cigarette smoking.  
Periconceptional smoking is consistently associated with a modest increase in orofacial 
clefts, particularly CL/P.52,54  Though linear dose-response trends across levels of smoking 
have not been observed, heavy smoking (>25 cigarettes per day) is most strongly associated 
with having an OFC-affected pregnancy (OR = 1.8; 95% CI = 1.1 to 2.9).52   This 
observation could be explained by misclassification of smoking at lower levels, or it could 
indicate a threshold effect whereby the risk of OFCs is impacted only by maternal smoking at 
higher levels of exposure.  Several studies have also found maternal alcohol consumption to 
be associated with OFCs, though estimates vary by amount, timing, and type of alcohol.55-60  
Low-level consumption, for example, does not seem to be as strongly associated.61  
Interestingly, a recent NBDPS study reported an interaction between the type of alcohol 
consumed and folic acid intake as risk factors for CP.62  Folic acid antagonists, such as 
alcohol, have been previously shown to be associated with an increased risk of OFCs.63  
Table 5 lists several factors suspected of being associated with OFCs; those indicated in 
italics are considered known risk factors.   
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Table 5.  Factors associated with orofacial clefts 
Maternal and fetal factors Environmental factors 
Alcohol use 
Birth order 
BMI (>29) 
Diabetes 
Folic acid 
Hyperthermia and febrile illness 
Infant sex  
Nutritional status 
Family history of OFCs 
Race/ethnicity 
Smoking 
Stress 
Therapeutic drug use1 
Air pollution 
Altitude 
Chlorination disinfection byproducts  
Environmental estrogens 
Ionizing radiation 
Organic solvents 
Pesticides and herbicides 
Proximity to landfills 
Some occupations 
1
 Therapeutic drugs include anticonvulsants, corticosteroids, folic acid antagonists, and vitamin-A formulas such as 
Accutane® 
Abbreviations: BMI = body mass index; OFCs = orofacial clefts 
Sources: Hayes (2006); Honein (2007); Larsen (2001); Murray (2002); Shaw (2006) 33,52,64-66 
 
Several pathogenic processes are thought to affect OFCs.33  Cleft lip can be caused by 
inadequate migration or proliferation of neural crest cells that contribute to the development 
of the face, or it can be caused by excessive or targeted cell death during development of the 
craniofacial features.  Cleft palate can be the result of inadequate growth of the palatine 
shelves, failure of the shelves to fuse, or secondary rupture after fusion.  Animal models 
suggest that toluene and other organic solvents may induce OFCs through mechanisms 
similar to those observed with alcohol.2,30,67  Refer to Section 1.1.3 for a description of the 
proposed biologic mechanisms by which organic solvent exposure may be associated with an 
increased risk of orofacial clefts.   
1.3.4  Public health impact  
Nearly a half billion dollars is spent each year on medical care for infants born with 
an OFC in the United States.50  Individuals with orofacial clefts require significant medical 
attention as well as nutritional, dental, speech, and behavioral interventions.65,68  Most cases 
of CL and CP can be repaired to some degree, but affected infants often require special 
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feeding intervention until surgeries can be performed.  Typically, the lip is repaired by 3 
months and the palate by 1 year.  Affected individuals may face other adverse medical issues 
since approximately 70 percent of CL/P and 50 percent of CP cases are syndromic,65 and 
more than 25 percent of all OFC cases are affected by multiple birth defects.69   
Relatively little is known about the long-term effects of OFCs; however, there is 
mounting evidence that cases have increased all-cause mortality as adults, as well as 
increased risk for cancer, cardiovascular events, and suicide.51  The physical, psychosocial 
and economic burden associated with orofacial clefts makes the reduction of these congenital 
anomalies an important public health effort. 
1.4  Review of the epidemiological literature 
This section describes and summarizes the body of epidemiologic studies 
investigating the association between maternal organic solvent exposure and NTDs and 
OFCs.  Interest in adverse perinatal effects due to solvent exposure during pregnancy dates 
back several decades, with perhaps the most seminal studies of neural tube and orofacial 
clefts being conducted in the early 1980’s by Holmberg et al. in Finland.70-72  In general, 
most early studies observed a moderate positive relationship between solvent exposure and 
birth defects.70-75  However, the collection of early studies is less methodologically 
sophisticated than recent investigations and interpretations of their results are thus subject to 
various limitations including confounding, recall bias, and exposure misclassification.  
Therefore, the summary presented here is limited to relevant studies published after 1990 
with the intention of focusing on the most valid investigations and sound results.  Further 
exclusion criteria (with citations for select examples) are as follows: 
 Environmental (i.e. non-occupational) exposure 76-78 
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 Studies of other solvents, such as glycol ethers 79,80 
 Studies where outcome is “any major malformation” 81-83 
 Studies of birth defects other than NTDs or OFCs 84 
 Studies of solvent-exposed occupations (e.g. “laboratory workers”) unless 
organic solvents are considered to be the primary chemical exposure 83,85 
 Studies of paternal occupational exposure to organic solvents 86,87 
 Studies of highly selective non-representative populations, such as studies of 
women who self-identified to occupational health clinics for suspected solvent 
exposure 88,89 
 Case reports or case series (i.e. non-analytic studies) 
 
Though many of the studies in the review presented here have been previously 
summarized in formal reviews of the literature,67,90-92 we include additional studies published 
thereafter.  The studies summarized in the following sections share some important study 
characteristics that help to inform an assessment of the quality of the research as well as help 
to potentially explain inconsistencies across study results.  The primary study characteristics 
to be considered are study population, outcome classification, exposure assessment, exposure 
window, and exposure prevalence.  Refer to Tables 6-7 for additional study details. 
1.4.1  Studies of NTDs 
Five studies meeting the aforementioned inclusion criteria for this review have 
examined the association between maternal occupational exposure to organic solvents and 
neural tube defects (Table 6).93-97  This section briefly highlights their study characteristics 
and results.  
Study population:  Two studies were conducted in France (Cordier 1992; Garlantezec 
2009), one in Mexico (Aguilar-Garduno 2010), one in California (Shaw 1999) and one in 
Texas (Brender 2002).  The latter study focused exclusively on births to Mexican-American 
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women along the Texan-Mexican border. Three studies obtained cases from hospitals; one 
from a population-based birth defect registry, and one observed cases that occurred within a 
population-based prospective cohort of pregnant women.  Outcome ascertainment:  All 
studies grouped isolated cases of any NTD together except Aguilar-Garduno et al., who 
exclusively focused on anencephaly.  Shaw et al. reported that effects were also estimated for 
spina bifida and anencephaly individually.  Exposure assessment:  All studies employed an 
industrial hygienist to classify exposure to “any solvent” based on self-reported occupational 
histories.  The two studies conducted in the U.S. also classified exposure to solvents resulting 
from hobby activities.  Garlantezec et al. also considered self-reported exposure to multiple 
products considered to contain solvents.  Cordier et al. distinguished between exposure to 
solvents in pure form and exposure to solvent-containing products.  Exposure window:  The 
critical period for teratogenic induction of NTDs is considered to be the 4th week of 
gestation.  Both Brender et al. and Shaw et al. considered exposure during the perinatal 
period, defined as 3 months prior to conception to 3 months after conception.  Cordier et al. 
and Garlantezec et al. restricted their analysis to mothers with jobs held “at the beginning of 
pregnancy”.  Aguilar-Garduno et al. focused on exposure that occurred 3 months before and 
one month after the last menstrual period.  Exposure prevalence:  Shaw et al. and Cordier et 
al. found a similar proportion of exposed controls: 38 and 32 percent, respectively.  In the 
study by Garlantezec et al., 47% of controls self-reported occasional or regular exposure to 
solvents, whereas the JEM-estimated exposure prevalence among controls was 
approximately 20%.  In the other studies, no controls were estimated to be exposed.  Results:  
Brender et al. estimated the odds ratio (OR) for occupational exposure only and any NTD to 
be infinite (95% CI = 1.8 to ∞; 7 exposed cases) since no controls were exposed.  For any 
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solvent exposure (occupational or hobby), the OR was 2.5 (98% CI = 1.3 to 4.7; 36 exposed 
cases).  Notably, furniture stripping and refinishing was the hobby most strongly associated 
with NTD-affected pregnancies (OR = 4.4; 95% CI = 0.8 to 31.1).  Shaw et al. did not find 
an association between NTDs and either occupational or hobby exposure to organic solvents 
in general; the OR for combined exposure was 0.89 (95% CI = 0.69 to 1.1; 211 exposed 
controls).  Cordier et al. also did not find an association between occupational exposure to 
any organic solvent (OR for frequency >50% of workday = 1.2; 90% CI = 0.4 to 4.4; 5 
exposed cases).  However, effect estimates were elevated for exposure to solvent-containing 
products on the job (OR for frequency >50% of workday = 2.0; 90% CI = 0.7 to 6.7; 8 
exposed cases).  Garlantezec et al. observed only 1 exposed NTD case; the OR for self-
reported and JEM-estimated exposure was 6.58 (95% CI = 0.7 to 63.9) and 1.30 (95% CI = 
0.1 to 12.5), respectively.  Eight cases of anencephaly (5.5% of all cases) were estimated to 
be exposed to solvents in the study by Aguilar-Garduno et al.,but no OR was estimated 
because no controls were considered exposed.   
1.4.2  Studies of OFCs 
This section briefly highlights the study characteristics and results of five studies 
meeting the aforementioned inclusion criteria for this review that have examined the 
association between maternal occupational exposure to organic solvents and orofacial clefts 
(Table 7) 93,96,98-100.  Note that Cordier et al. (1992) and Garlantezec et al. (2009) investigated 
both OFCs and NTDs.   
Study population:  Three of five studies were conducted using cases obtained in 
hospitals or surgical centers in France (Chevrier 2006; Laumon 1996; Cordier 1992), one was 
conducted within a prospective cohort of pregnant women in France (Garlantezec 2009) and 
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one was conducted using cases across Europe identified through a population-based birth 
defect registry (Lorente 2000).   Outcome ascertainment:  Three studies combined all cases 
of cleft lip and palate, whereas the other two examined CP and CL/P individually.  Exposure 
assessment:  All studies employed an industrial hygienist to classify exposure to solvents 
based on self-reported occupational histories.  Garlantezec et al. also considered self-reported 
exposure to multiple products considered to contain solvents.  Cordier et al. distinguished 
between exposure to solvents in pure form and exposure to solvent-containing products.  The 
other three studies estimated exposure to specific solvents or solvent classes.  Exposure 
window:  For OFCs, the critical period of development is considered to be from the 6th to 
10th week of gestation.  Each of the five studies estimated exposure at different time periods 
ranging from the first two months of pregnancy to anytime during pregnancy.  Exposure 
prevalence:  The exposure prevalence among controls varied substantially across these case-
control studies: Chevrier et al. estimated 39 percent of controls to be exposed to any solvent.  
In the study by Garlantezec et al., 47% of controls self-reported occasional or regular 
exposure to solvents, whereas the JEM-estimated exposure prevalence among controls was 
approximately 20%.  In the population-based European study, the estimated exposure 
prevalence for toluene, aromatic hydrocarbons, and trichloroethane was 1 percent, 4 percent, 
and less than 1 percent, respectively.  Cordier et al. estimated that 11 and 21 percent were 
exposed to pure solvents and solvent-containing products, respectively.  Laumon et al. did 
not report exposure prevalence.  Results:  Chevrier et al. reported elevated odds of both CP 
(OR = 3.78; 95% CI = 0.7 to 20.7 3 exposed cases) and CL/P (OR = 9.45; 95% CI = 2.5 to 
35.3; 14 exposed cases) with any exposure to chlorinated solvents.  Significantly elevated 
odds of OFCs were also observed for petroleum solvents, for which a positive trend was 
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observed for increasing exposure score (based on intensity, frequency, and rater reliability) 
and CL/P (p<0.01).  Generally, higher estimates were observed in this study for CL/P than 
CP alone for any solvent.  In contrast, Lorente et al. found larger estimates for CP alone than 
CL/P, though odds ratios for both defect groups were elevated.   The OR for CP alone was 
3.02 (95% CI = 0.93 to 9.84; 4 exposed cases) for exposure to aromatic hydrocarbons, 6.47 
(95% CI = 1.02 to 40.9; 2 exposed cases) for trichloroethylene, and 6.73 (95% CI = 1.19 to 
38.0; 2 exposed cases) for toluene.  Laumon et al. combined all cases of orofacial clefts and 
reported moderately elevated estimates for exposure to any solvent (OR = 1.62; 95% CI = 
1.04 to 2.52), aromatic solvents (OR = 1.78; 95% CI = 0.89 to 3.54), and halogenated 
solvents (OR = 4.40; 95% CI = 1.41 to 16.15).  However, these estimates were unadjusted for 
any potential confounding factors.  Cordier et al. also combined all cases and observed 
highly elevated odds of any OFC with exposure to solvents in pure form (OR = 7.9; 90% CI 
= 1.8 to 44.9; 7 exposed cases) or to solvent-containing products (OR = 6.8; 90% CI = 0.2 to 
40.1; 4 exposed cases).  Garlantezec et al. observed an increased odds for combined all cases 
of OFCs combined (n=8) associated with both self-reported exposure to any solvent-
containing product (OR = 3.60; 95% CI = 0.8 to 16.0; 5 exposed cases) and JEM-assessed 
exposure to any organic solvent based on job title (OR = 12.85; 95% CI = 2.6 to 64.7; 6 
exposed cases).   
1.4.3  Overall summary and limitations of previous research 
In general, evidence supporting an association between maternal occupational 
exposure to organic solvents and NTDs and OFCs is inconsistent.  The observed relationship 
seems to be strongest for OFCs and less so for NTDs.  Inconsistency across studies could be 
explained by differences in study population, exposure assessment, or outcome 
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ascertainment.  Most studies, however, report positive findings; it is unclear whether this is 
due to publication bias or whether these studies reveal a true underlying etiologic association.  
As previously discussed in this chapter, the role of organic solvent exposure in the 
development of defects originating from neural crest cells is biologically plausible, though 
potential mechanisms of toxicity are not well understood.   
The recent epidemiologic studies investigating the relationship between maternal 
occupational organic solvent exposure and congenital anomalies reviewed in Section 1.4 are 
superior to previous work in that they apply improved methods for study design, exposure 
assessment, and data analysis.  For example, most studies employed industrial hygienists to 
carefully review self-reported occupational histories and classify exposure by probability or 
frequency.  This method is preferable to using self-reported exposure directly since it can 
reduce recall bias as well as exposure misclassification.  Also, results from recent studies are 
adjusted for potentially confounding factors such as maternal age, BMI, and smoking.   
Despite these strengths, this collection of studies also shares limitations. 
Exposure assessment is arguably the study characteristic with the most potential to 
directly influence observed results.  In the absence of personal monitoring data, occupational 
exposure assessment methods are particularly sensitive to misclassification that can bias 
study results in either direction (i.e. toward or away from the null) to various degrees.  
Assessment by expert review is perhaps the optimal method available to most epidemiologic 
studies that must rely on indirect retrospective assessment.101  Evaluations of  generic job-
exposure matrices (JEMs) in studies of organic solvent exposure as well as studies of birth 
defects suggest that sensitivity and specificity are often unsatisfactory and that hybrid JEMs 
that are study-specific and informed by expert review perform better.101-103   
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Even with a perfect method of exposure assessment, studies of organic solvent 
exposure are challenged by the fact that most occupational exposure is to solvent mixtures 
and not to individual compounds.  This fact limits the ability of studies to isolate specific 
putative solvent exposures from others that may have no effect.  Chevrier et al. (2006) 
attempted to compare women exposed to one solvent class with women unexposed to any 
solvent; the intended analysis could not be implemented given that all women exposed to 
chlorinated solvents in their study population were additionally exposed to either petroleum 
or oxygenated solvents.100  Grouping exposure to “any solvent” is also problematic since 
concurrent exposure can have additive, synergistic, or antagonistic joint effects on the risk of 
adverse outcomes.   
Choice of study population differed across these studies.  Some studies included 
singleton births only, or restricted their sample to liveborn infants, which may introduce 
selection bias.  Given the range of study populations, exposure assessment methods and 
exposure windows, it is not surprising that the exposure prevalence also ranged widely across 
these studies.  However, there does not seem to be a pattern between exposure prevalence 
and magnitude of the observed effect estimates in this collection of studies.   
Choice of referent group for analysis also differed across these studies.  Some studies 
restricted eligible participants only to women who were working during the exposure period 
of interest; in these studies, exposed working women were compared to non-exposed 
working women.  Other studies, however, included non-working women in the referent 
group.  This latter approach can introduce confounding by factors such as SES.   
Only the most salient issues specifically pertinent to studies of maternal occupational 
organic solvent exposure and NTDs and OFCs have been highlighted in this section.  
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Numerous other methodological considerations specific to epidemiologic studies of chemical 
exposures and birth defects have been discussed at length in the literature.104,105  A recent 
review of occupational exposure to glycol ethers and congenital malformations developed a 
series of sensitivity analyses to show that both positive and null findings in the literature are 
quite sensitive to several methodological problems including selection bias due to 
unrecognized SAB, case non-response, or non-random control selection, as well as exposure 
misclassification and residual confounding.106  For example, given a plausible range of 
sensitivity and specificity for exposure classification, the sensitivity analysis suggested that 
odds ratios observed by Cordier et al. (1997) for glycol ether exposure and CL/P could be 1.1 
to 1.8 times the “corrected” OR resulting from perfect exposure classification.  Similarly, 
given a plausible range of case response proportions, the same odds could be 0.7 to 1.6 times 
the “corrected” OR resulting from complete case response.  Despite the sensitivity of results 
to such errors, weak or moderate associations that consistently recur across studies with 
different methodological characteristics may reflect true underlying mechanisms of 
teratogenesis and warrant further investigation.107   
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Table 6.  Summary of epidemiologic studies investigating maternal occupational organic solvent exposure and neural tube defects 
Author (year) 
Location 
Study Characteristics Exposure Assessment Adjustment Covariates Results 
OR (95% CI); # exposed cases 
    
 
Aguilar-
Garduno et al. 
(2010) 
 
Mexico 
Design: case-control 
 
Study population: Births 
identified by the Mexican 
Epidemiologic Surveillance 
System (2000-2001) 
 
Outcome: anencephaly 
(n=151), and 151 controls 
Exposure period: between 3 months 
prior to LMP and 1 month after LMP 
 
Exposure assessment: IH review of 
self-reported occupational history 
 
Exposure prevalence in controls: no 
controls were exposed to solvents 
Frequency matched by date 
of birth and delivery facility 
 
Models adjusted for maternal 
age, SES, adverse 
reproductive history, folic 
acid intake, caloric intake, 
cooking with wood, coal or 
tires 
 
Any solvent  
8 cases (5.5%) exposed & 
0 controls exposed; 
effect estimate not reported  
    
 
Garlantezec et 
al. (2009) 
 
France 
Design: prospective cohort 
 
Study population: 3,421 
pregnant women in Brittany 
(2002- 2005) 
 
Outcome: any CNS defect 
combined (n=4) 
Exposure period: early pregnancy 
based on employment at 19 weeks 
 
Exposure assessment: self-reported 
exposure and job-exposure matrix 
 
Exposure prevalence in controls: 47% 
based on self-report; 20% by JEM 
Models adjusted for tobacco 
and alcohol consumption 
 
Other factors considered but 
not adjusted for included 
maternal age and education 
Any solvent  
Based on self-reported exposure 
   6.58 (0.7 – 63.9); 3 
 
Based on JEM-estimated 
exposure 
   1.30 (0.1 – 12.5); 1 
    
    
 
Brender et al. 
(2002) 
 
Texas 
Design: case-control 
 
Study population: Births 
among Mexican-American 
women (1995- 2000) 
 
Outcome: any isolated NTD 
combined (n=225), and 378 
controls 
Exposure period: between 3 months 
prior to conception and 3 months after 
conception 
 
Exposure assessment: IH review of 
self-reported occupational history 
 
Exposure prevalence in controls: no 
controls were exposed to solvents 
Frequency matched by year 
of birth and delivery facility 
 
Models adjusted by BMI and 
maternal age 
 
Maternal smoking was not 
found to be a confounder 
Any solvent  
Occupational exposure only 
   ∞ (1.8 – ∞); 7  
 
Hobby exposure only 
   1.9 (1.0 – 3.6); 27  
 
Combined exposure 
   2.5 (1.3 – 4.7); 36  
 
continued on next page…   
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Shaw et al. 
(1999) 
 
California 
Design: case-control 
 
Study population: Singleton 
births (liveborn, stillborn, or 
electively terminated) at 
hospitals in CA (1989-1991) 
 
Outcome: any isolated NTD 
(n=538), and 539 non-defect 
controls 
Exposure period: between 3 months 
prior to conception and 3 months after 
conception 
 
Exposure assessment: IH review of 
self-reported occupational history and 
job-exposure linkage for task-specific 
exposures 
 
Exposure prevalence in controls: 38% 
for occupational exposure only 
Unadjusted 
 
Maternal education, 
race/ethnicity, and 
multivitamin use were not 
found to be confounders 
Any solvent  
Occupational exposure only 
   0.97 (0.71 – 1.3); 158  
 
Hobby exposure only 
   1.1 (0.66 – 1.7); 45  
 
Combined exposure 
   0.89 (0.69 – 1.1); 211 
    
 
Cordier et al.* 
(1992) 
 
France 
Design: case-control 
 
Study population: Births at 
hospitals in Paris or Marseille 
(1984-1987) 
 
Outcome: any isolated CNS 
defect combined (n=83), and 
83 controls 
Exposure period: restricted to jobs held 
“at beginning of pregnancy” 
 
Exposure assessment: IH review of 
self-reported occupational history; 
classified by frequency 
 
Exposure prevalence in controls: 32% 
for pure solvents; 36% for solvent-
containing products  
Individually matched by 
delivery hospital 
 
Models adjusted for 
residential area, maternal age 
and SES 
Any solvent 
Any frequency 
   1.0 (0.4 – 2.4); 12  
Frequency >50% of workday 
   1.2 (0.4 – 4.4); 5 
 
Any solvent-containing product 
Any frequency 
   1.4 (0.6 – 3.2); 15  
Frequency >50% of workday 
   2.0 (0.7 – 6.7); 8 
* 90% CIs in this study 
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Table 7.  Summary of epidemiologic studies investigating maternal occupational organic solvent exposure and orofacial clefts 
Author (year) 
Location 
Study Characteristics Exposure Assessment Adjustment Covariates Results 
OR (95% CI); # exposed cases 
Garlantezec et 
al. (2009) 
 
France 
Design: prospective cohort 
 
Study population: 3,421 
pregnant women in 
Brittany (2002- 2005) 
 
Outcome: any orofacial 
cleft defect combined 
(n=8) 
Exposure period: early 
pregnancy based on 
employment at 19 weeks 
 
Exposure assessment: self-
reported exposure and job-
exposure matrix 
 
Exposure prevalence in 
controls: 47% based on self-
report; 20% by JEM 
Models adjusted for 
maternal age, education 
level, tobacco and alcohol 
consumption 
Any solvent 
   self-reported exposure         3.60 (0.8 – 16.0); 5 
   JEM-estimated exposure     12.85 (2.6 – 64.7); 6  
                                  
 
Chevrier et al. 
(2006) 
 
France 
Design: case-control 
 
Study population: Infants 
hospitalized at 9 hospitals 
(1998-2001) whose 
mothers all worked during 
the first trimester 
 
Outcome: CP (n=76), CL/P 
(n=164), and 236 controls 
Exposure period: 1st trimester 
 
Exposure assessment: IH 
review of self-reported 
occupational history; classified 
by intensity, frequency, and 
reliability  
 
Exposure prevalence in 
controls: 39% to any solvent 
Frequency matched by 
sex, age, geographic origin 
and residence 
 
The following factors 
were not found to be 
confounders: maternal 
smoking, alcohol intake, 
and first trimester dietary 
folate intake   
Chlorinated solvents 
   any vs. none                  CL/P: 9.45 (2.5 – 35.3); 14 
                                         CP: 3.78 (0.7 – 20.7); 3 
 
Petroleum solvents 
   any vs. none      CL/P: 3.64 (1.5 – 8.8); 17    
                              CP:   1.21 (0.3 – 20.7); 3 
   very low-low vs. none  CL/P:  3.21 (1.1 – 9.3); 10   
   medium-high vs. none  CL/P:  4.60 (1.1 – 19.2); 7 
                                           ptrend < 0.01 for CL/P 
Lorente et al. 
(2000) 
 
Europe 
Design: case-control 
 
Study population: Births 
identified by the European 
Registration of Congenital 
Anomalies (1989-1992) 
 
Outcome: CL/P (n=64), CP 
(n=36), and 751 controls 
Exposure period:  any time 
during pregnancy 
 
Exposure assessment: IH 
review of self-reported 
occupational history; classified 
by probability and frequency 
 
Exposure prevalence in 
controls: 1% for toluene; 4% 
for aromatic hydrocarbons; <1% 
for trichloroethane 
Models adjusted for 
center, maternal age, SES, 
urbanization, and country 
of origin 
Aromatic hydrocarbons 
   any vs. none                   CL/P: 1.79 (0.62 – 5.16); 5 
 CP: 3.02 (0.93 – 9.84); 4 
Trichloroethylene 
   any vs. none                   CL/P: 3.21 (0.49 – 20.9); 2 
 CP: 6.47 (1.02 – 40.9); 2 
Toluene 
   any vs. none                   CL/P: 1.61 (0.15 – 17.7); 1 
 CP: 6.73 (1.19 – 38.0); 2 
 
continued on next page…   
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Author (year) 
Location 
Study Characteristics Exposure Assessment Adjustment Covariates Results 
OR (95% CI); # exposed cases 
Laumon et al. 
(1996) 
 
France 
Design: case-control 
 
Study population: Infants 
presenting for outpatient 
facial surgery at 6 centers 
in Rhone-Alpes (1985-
1989) 
 
Outcome: non-syndromic 
CL/P and CL combined 
(n=200), and 400 controls 
Exposure period: 1st two 
months of pregnancy 
 
Exposure assessment: IH 
classification of self-reported 
exposure to solvents 
 
Exposure prevalence in 
controls: not reported 
Unadjusted Any solvent 
1.62 (1.04 – 2.52)  
 
Aromatic solvents 
1.78 (0.89 – 3.54) 
 
Halogenated solvents 
4.40 (1.41 – 16.15) 
 
Cordier et al.* 
(1992) 
 
France 
Design: case-control 
 
Study population: Births at 
hospitals in Paris or 
Marseille (1984-1987) 
 
Outcome: isolated CL and 
CP combined (n=29), and 
29 non-defect controls 
Exposure period: restricted to 
jobs held “at beginning of 
pregnancy” 
 
Exposure assessment: IH 
review of self-reported 
occupational history; classified 
by frequency 
 
Exposure prevalence in 
controls: 11% for pure solvents; 
21% for solvent-containing 
products  
Individually matched by 
delivery hospital 
 
Models adjusted for 
residential area, maternal 
age and SES 
Any pure solvent 
Any frequency 
   7.9 (1.8 – 44.9); 7 
Frequency >50% of workday 
   ∞ (0.4 – ∞); 3 
 
Any solvent-containing product 
Any frequency 
   6.8 (0.7 – 128.3); 8 
Frequency >50% of workday 
   2.2 (0.2 – 40.1); 4 
* 90% CIs in this study 
 
 
 CHAPTER 2: STATEMENT OF SPECIFIC AIMS 
Toxicologic and epidemiologic evidence suggest a possible association between 
maternal occupational exposure to organic solvents and the risk of congenital anomalies.  
Though findings in recent investigations are inconsistent due to methodological differences 
and other factors, this potential association warrants further inquiry since many women work 
during early pregnancy and organic solvents are commonly used in various workplaces.  The 
primary purpose of this research was to advance our knowledge about the potential relation 
between maternal occupational exposure to organic solvents during pregnancy and the risk of 
neural tube defects and orofacial clefts in offspring.  The National Birth Defects Prevention 
Study (NBDPS), one of the largest ongoing population-based case-control studies of risk 
factors for major structural congenital anomalies, was for many reasons a notable framework 
in which to examine this research question and improve upon the methods of previous work.  
The available study population, for example, consisted of a large, population-based sample of 
demographically diverse mothers of carefully classified cases and controls delivered 
relatively recently in 8 states across the United States, including cases among fetal deaths and 
terminations from the majority of study sites.  In addition, self-reported occupational 
histories and expert-assessed determinations of exposure to 10 organic solvents were 
available for up to 6 jobs that mothers reported having three months before and during 
pregnancy.      
Particularly for studies of pregnancy outcomes that are most vulnerable during a 
specific period of development, like congenital anomalies, accurate assessment of prenatal 
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exposures requires evaluation of exposure during the appropriate time window.  The effects 
of exposure misclassification due to exposure variability across critical time windows in 
studies of pregnancy outcomes have been described in the literature 16,108.  In short, greater 
variability in exposure across different time periods results in greater exposure 
misclassification when exposure is considered “anytime during pregnancy.”  However, if 
exposure is known to be invariable over the course of pregnancy, then the collection of 
timing-specific exposure may not be necessary.  Little is known about the timing, pattern, 
and prevalence of occupational exposure to organic solvents during pregnancy.  Therefore, 
we were also interested in exploring the prevalence and patterns of maternal employment and 
estimated solvent exposure during pregnancy.  The specific aims of this dissertation project 
are as follows: 
 
AIM 1: to explore the prevalence and pattern of occupational exposure to organic 
solvents among women before and during pregnancy 
 
Specifically, to: 
• determine estimated solvent exposure prevalence across different time 
periods before and during pregnancy 
• describe within-woman variability in exposure status across different time 
periods before and during pregnancy 
• estimate the magnitude and direction of bias resulting from 
misspecification of the critical window of exposure 
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AIM 2: to evaluate the impact of maternal occupational organic solvent exposure on 
selected major structural birth defects  
 
Specifically, to: 
• estimate the effect of estimated occupational exposure during the 
periconceptional period on the prevalence of NTDs and OFCs 
• evaluate effect heterogeneity across component phenotypes of NTDs and 
OFCs 
 
 CHAPTER 3: METHODS 
Chapter 3 describes the general analytic framework and methods for this research 
project.  Additional descriptions of the methods are included in the manuscripts (Sections 
4.2.2 and 4.3.2). 
3.1  Study population 
The National Birth Defects Prevention Study is an ongoing, multi-center, population-
based case-control study designed to investigate genetic and environmental factors associated 
with over 30 major congenital defects.109  It began in 1997, and is among the largest 
collaborative birth defect case-control studies in the United States.  The study is sponsored 
by the CDC, which coordinates a group of Centers for Birth Defects Research and Prevention 
(CBDRP) that contribute to the study using data from local population-based birth defect 
surveillance systems.  The annual birth population covered by the CBDRP (i.e. the sampling 
frame for cases and controls) represents approximately 10 percent of all U.S. births.  
Currently, there are 9 participating centers including Arkansas, California, Iowa, 
Massachusetts, New York, North Carolina, Texas, Utah, and a CDC-based center in Atlanta, 
Georgia; participating centers have changed over time. 
3.1.1  Case and control ascertainment  
Each center contributes approximately 300 cases and 100 controls to the study 
annually.  Methods for case and control ascertainment vary by center.  Potentially eligible 
cases are identified from each participating state’s birth defect surveillance system.  Some 
centers ascertain cases statewide (AR, IA, MA, NJ, UT), and others cover only selected areas 
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of the state (CA, NC, NY, TX, CDC).  Cases include live births (all centers), fetal deaths 
greater than 20 weeks gestation (AR, CA, IA, MA, NC, TX, UT, CDC), and prenatally 
diagnosed elective terminations (AR, CA, IA, NC, TX, UT, CDC) with estimated or actual 
dates of delivery (EDD) on or after 01 October 1997 (01 January 1998 for AR and NJ; 01 
January 2003 for NC and UT) who were diagnosed with at least one eligible birth defect of 
interest within the first year of life.  New Jersey contributed cases and controls through 31 
December 2002.  
Controls include live births without a major defect with an EDD during the same time 
frame as cases.  Controls are randomly selected from hospital delivery records (AK, CA, NY, 
TX, and CDC through 2000) or birth certificates (IA, MA, NC, NJ, UT and CDC since 
2001).  Though small differences exist between controls selected from hospital vs. controls 
selected from birth certificates, the combined population of controls is similar to target 
populations with regard to demographic and health factors including maternal age, 
race/ethnicity, and timing of entry into prenatal care.110  
Additional eligibility criteria apply.  Case and control infants must be in the custody 
of and reside with the birth mother to be eligible for the study.  Birth mothers must be alive at 
the time of enrollment and speak either English or Spanish to be eligible. 
3.1.2  Case classification  
Case classification is standardized across all contributing centers.  Clinical geneticists 
at each center review pertinent case information abstracted from medical records to 
determine eligibility for study inclusion.  Eligible cases are then reviewed again by a team of 
NBDPS clinicians to confirm eligibility and to distinguish whether a case has the defect of 
interest as an isolated defect (e.g. no additional major, unrelated defects), as one of multiple 
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congenital anomalies (e.g. two or more major, unrelated defects), or as a component of a 
known syndrome, sequence or association.  Cases with defects of known etiology (e.g. 
single-gene disorders and chromosomal anomalies) are excluded.  An important purpose of 
the uniform case classification process is to apply what is known about embryologic and 
pathogenetic mechanisms to make case groups for analysis more comparable while 
respecting important etiologic heterogeneity between defects.111   
3.2  Data collection 
NBDPS collects information about participants from multiple sources: (1) medical 
and hospital records for case infants are reviewed for classification purposes; (2) mothers of 
cases and controls are interviewed; and (3) parents of cases and controls are asked to collect 
buccal cells from themselves and their infants as a source of DNA.  Standard procedures are 
used for contacting, recruiting, and enrolling mothers of case and control infants, as well as 
for obtaining informed consent for all data collection procedures.109  Contact with mothers is 
first established no earlier than 6 weeks after the infant’s EDD.  Monetary incentives are 
offered for completed participation in both the interview and collection of biologics.   
3.2.1  Maternal interview 
A structured computer-assisted telephone interview (CATI) Mother Questionnaire is 
administered in English or Spanish by female interviewers between 6 weeks and 24 months 
after the EDD.  The average infant age at interview was 10 months for NTD cases, 10 
months for OFC cases and 8 months for controls.  The CATI takes approximately one hour 
and covers a wide range of health and environmental topics including demographic, physical, 
behavioral, nutritional, and chemical factors.   Mothers are asked to report pre-conceptional 
and post-conceptional illness, medication use, vitamin use, residence, occupation, substance 
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abuse, information on the index pregnancy, and family history of birth defects.  See Section 
3.3 for a description of the occupational history section of the maternal interview.   
3.2.2  Participation rates 
Participation rates are calculated by case-control status, race/ethnicity, and defect 
group.  The following participation rates are calculated by the NBDPS and are specific to the 
study population of cases included in this research project (i.e. EDD from study start date 
through 12/31/2002).  The overall study participation rate (i.e. participation in the interview) 
was 72 percent for cases and 69 percent for controls.  Among cases, non-Hispanic whites 
were more likely to participate (75%) than Hispanics or non-Hispanic blacks (65 and 63%, 
respectively).  The same pattern held among controls.  Defect-specific rates also varied 
slightly.  Seventy percent of NTD cases participated; mothers of cases with spina bifida were 
more likely to participate than cases of anencephaly (74 vs. 63%, respectively).  The 
participation rate among cases of orofacial clefts (76%) did not vary by phenotype.  
3.3  Exposure assessment 
The occupational history section of the maternal interview (Appendix A) identified 
mothers who were employed for at least one month duration from three months preceding the 
EDC through the end of pregnancy.  Employment was defined as compensated, volunteer or 
military service, including part-time work and work performed at home.  For each reported 
job, mothers were asked about the employer, job title, primary tasks and duties, chemicals 
and machines handled on the job, dates of employment, and hours and days worked per 
week; up to 6 jobs could be recorded.  Jobs were then coded by occupation and industry 
according to the Standard Occupational Classification Manual (2000) 112 and North 
American Industry Classification System (1997).113  
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The National Institute for Occupational Safety and Health (NIOSH) led an initiative 
to perform a comprehensive occupational exposure assessments for women enrolled in the 
NBDPS through 2002.  Study investigators identified specific substances to include in the 
assessments based on published estimates of exposure prevalence in the workplace and 
evidence in the scientific literature relating these agents to birth defects and other adverse 
health outcomes.  Agents of interest included: chlorinated solvents, aromatic solvents , 
Stoddard solvent, glycol ethers, oil mist, polycyclic aromatic hydrocarbons (PAHs), 
pesticides, and metals.  This dissertation research includes exposure data from assessments 
performed for 10 organic solvents including 3 aromatic solvents (benzene, xylene, toluene), 6 
chlorinated solvents (carbon tetrachloride, chloroform, methylene chloride, 
perchloroethylene, trichloroethylene, 1,1,1-trichloroethane), and the petroleum-based mixture 
Stoddard solvent (also known as mineral or white spirits).     
3.3.1  Assessment strategy 
Comprehensive era-specific (1997-1999; 2000-2002) and solvent-specific job-
exposure databases were developed for NBDPS by a team of occupational epidemiologists 
and industrial hygienists (IH) contracted by NIOSH.  These job-exposure databases, based on 
extensive literature reviews of published papers reporting direct measurements and 
determinants of exposure for various occupations and industries, were then used in 
combination with IH review of self-reported job information to estimate the probability, 
intensity, and frequency of exposure for each reported job.  Probability was defined as the 
likelihood that a specific job within an industry within a given era had any exposure to the 
solvent; each job was assigned one of the following categories for exposure probability: 0 
(unexposed), <10%, 10-49%, 50-89% and ≥90%.  Intensity was defined as the expected 
 41
concentration (ppm or mg/m3) of solvent in the woman’s breathing zone.  Frequency was 
defined as the expected number of hours per week of exposure to the solvent, based on a 40-
hour work week.   
3.3.2  Estimated exposure prevalence 
Approximately 12,500 jobs among 10,528 mothers who delivered between October 
1997 and December 2002 were assessed for potential exposure to 10 organic solvents.  Table 
8 presents the distribution of estimated exposure to each of the solvents of interest. 
 
Table 8.  Distribution of estimated exposure to organic solvents among all jobs reported by 
NBDPS participants anytime during pregnancy or 3 months before conception, 1997-2002. 
Solvent Unique jobs (n=12,536)   
 Unknown Not exposed Exposed   
 n n n % Probability 
score (mode)* 
Aromatic solvents      
   Benzene 50 12,419 66 0.5 4 
   Toluene 49 12,255 231 1.8 4 
   Xylene 49 12,247 239 1.9 4 
Chlorinated solvents      
   Carbon tetrachloride 49 12,455 31 0.3 1 
   Chloroform 49 12,180 306 2.4 1 
   Methylene chloride 48 11,727 760 6.1 1 
   Perchloroethylene 48 12,057 430 3.4 1 
   Trichloroethane 48 11,725 762 6.1 1 
   Trichloroethylene 49 12,133 353 2.8 1 
Stoddard solvent 41 12,148 346 2.8 2 
*Exposure probability scores: 1 = <10%; 2 = 10-49%; 3 = 50-89%; 4 = and ≥90%.   
 
The prevalence estimates in Table 8 are among all of the jobs held for at least one 
month duration anytime during pregnancy or the 3 months preceding pregnancy among 
mothers of controls and cases of cardiovascular defects, musculoskeletal defects, neural tube 
defects, orofacial defects, and male reproductive tract defects with an EDD on or before 31 
December 2002.   
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3.3.3  Exposure characterization for analysis 
To determine estimated exposure at the mother level (rather the job level) for various 
time windows during pregnancy, employment dates were linked to pregnancy dates for each 
mother.   
Dates of employment obtained during the interview were recorded as the month and 
year that each job started and ended.  Therefore, we developed an algorithm to assign 
complete job dates consisting of day, month and year.  First, each job was assumed to begin 
on the first day of the reported starting month and end on the last day of the reported ending 
month.  Second, for mothers with multiple jobs, jobs overlapping by exactly one month were 
assumed to have been held consecutively and job dates were further modified such that the 
overlapping month was approximately evenly divided between jobs (i.e., Job 1 was modified 
to end on mm/14/yy and Job 2 was modified to start on mm/15/yy).  Any jobs overlapping by 
more than one month were assumed to have been held concurrently and job dates were not 
further modified.  Complete job dates were set to missing if the starting month, starting year, 
ending month or ending year was unknown, or if the starting and ending dates were 
inconsistent; these jobs were later reviewed manually to determine whether partial job dates 
were informative.    
Pregnancy dates reported during the interview included the date of the last menstrual 
period (LMP) and the infant’s date of birth (DOB).  The estimated date of conception (EDC) 
was calculated as the DOB-266 days, or LMP+14 days if the DOB was missing.  We 
constructed five pregnancy time windows of interest: (1) before pregnancy, defined as 90 
days preceding the EDC; (2) the first trimester, defined as the time between the EDC and 89 
days after the EDC; the periconceptional period, defined as the time between 30 days 
preceding the EDC and the end of the first trimester; (4) the second trimester, defined as the 
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time between 90 days after the EDC and 179 days after the EDC (or the DOB, whichever 
came first); and (5) the third trimester, defined as the time between 180 days after the EDC 
and the DOB.   
Job-level information was then summarized across women to obtain summary 
estimates of exposure for each mother for each time window of interest.  Thus, for each 
solvent, a mother was considered exposed if any of her jobs during the time window was 
rated as exposed (i.e., probability of exposure > 0 for any job).  She was considered 
unexposed if she did not have a job during the time window or if all her jobs during that 
window were rated as unexposed (i.e., exposure probability = 0 for all jobs).   
3.4  Data analysis 
All data management and analyses were conducted using SAS 9.1 (SAS Institute, 
Inc., Cary, NC) and Stata 9.2 (Statcorp, College Station, TX).   
3.4.1  Analytic plan for Aim 1: Prevalence of solvent exposure during pregnancy 
Aim 1 was to evaluate variability in occupational organic solvent exposure 
prevalence across different time periods of pregnancy.   
  Study population: The sample population included for this analysis included all 
mothers of NBDPS controls through 2002 who reported having at least one job (n ≈ 3,000).  
We focused exclusively on controls under the assumption that the control population (and 
therefore the distribution of estimated exposure among controls) is a representative sample of 
the general study population.   
Data analysis strategy:  First, self-reported pregnancy dates were linked with self-
reported employment dates to determine jobs that were held during different time periods 
before and throughout pregnancy.  Then, jobs were linked with exposure data to determine 
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whether mothers were estimated to be exposed to any solvent in the different time windows.  
Exposure was characterized dichotomously (i.e. any/none) to any solvent.  No further 
refinement in exposure (e.g. by solvent class, etc.) was considered under the assumption that 
variability in exposure is independent of the type of solvent to which a participant is 
primarily exposed.  However, the average duration of exposure within each window was 
calculated to evaluate whether exposures during certain windows were more likely to be 
transient.   
The next step was to evaluate exposure variability between windows.  For this 
analysis, we compared mutually exclusive windows using the Kappa statistic, which 
indicates the degree of concordance above and beyond what would be expected by chance 
alone.  We also constructed another measure of variability, which is the ratio of overall 
exposure prevalence to time-window-specific exposure prevalence (overall:time window 
[OTW] ratio).16  This measure was developed for a previous investigation of exposures 
during pregnancy to characterize variability across time and to make inferences about 
subsequent misclassification.  Assuming the distribution of exposure across pregnancy is 
known for all participants, the OTW ratio is defined as follows: 
OTW ratio = p / pi    
p = e/n, where: p = overall prevalence 
     e = number exposed out of n participants 
pi = ei/(n – di), where: ei = number exposed in time interval i 
     di = number who did not survive to time interval i 
As indicated in the formula above, the denominator of the time-specific prevalence 
excludes participants whose pregnancies ended prior to the start of the time window; this 
exclusion addresses survivor bias and is important since our study population includes fetal 
deaths, elective terminations, and live births of various gestational ages.  Interpretation of the 
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OTW ratio is straightforward: the higher the ratio, the greater the variability in terms of 
different participants being exposed across different time windows; high ratios that do not 
change across pregnancy imply that prevalence is similar across windows, but different 
people are exposed at different windows.  A consistently low OTW ratio implies that the 
same people are being exposed across time windows.  The advantage of the OTW ratio over 
other measures of concordance is that it can be used to evaluate how well a crude definition 
of exposure (i.e. “anytime during pregnancy”) performs relative to a more refined definition 
(i.e. “1st trimester only”), which is crucial when investigating the effect of a prenatal 
exposure on an outcome where the critically relevant exposure window may be narrow.   
Further, the OTW ratio has a direct relationship with exposure misclassification: the higher 
the ratio, the more misclassification is expected if exposure were considered anytime during 
pregnancy rather than during the narrower etiologically relevant window.   
Additional analyses:  Originally, we hypothesized that we would observe variability 
in solvent exposure status over the course of pregnancy, and thus we intended to conduct 
additional sensitivity analyses to empirically demonstrate the effect of misclassifying 
exposure during the biologically relevant critical window for congenital anomalies.  In 
actuality, very little variability in exposure status over the course of pregnancy was observed 
in these data (Section 4.1) and therefore further analyses were not conducted.  We then 
hypothesized that we did not observe variability in estimated exposure status over the course 
of pregnancy because exposure status was based on employment histories, which must have 
been very stable (i.e. no variability in employment status or occupation) over the course of 
pregnancy.  Using the same strategy of linking job dates with pregnancy dates described 
earlier in this Chapter, we examined the assumption that employment status was constant (i.e. 
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women who worked anytime during pregnancy worked for all of their pregnancy).  We 
considered a mother to be employed in a given time window if she worked at least one job 
during any portion of that window.  We calculated the prevalence of maternal employment 
anytime before and during pregnancy and for each time window of interest.  Among mothers 
employed anytime before and during pregnancy, we determined the proportion who 
experienced a change in employment status during pregnancy (e.g., from unemployed to 
employed) and the proportion who remained employed for the entire duration of their 
pregnancy.  We also examined the distribution of major occupations held by women with 
different employment patterns.  For these analyses, we extended our sample through 
December 2005 (n ≈ 7,000).   
3.4.2  Analytic plan for Aim 2: Solvent exposure and NTDs 
Aim 2 was to estimate the effect of maternal occupational solvent exposure during 
pregnancy on the prevalence of neural tube defects.   
Study population: The study population included employed mothers of cases of NTDs 
(n=521) and non-malformed controls (n=2997) delivered between 01 October 1997 and 31 
December 2002.   These mothers had participated in the NBDPS interview, reported having 
at least one job during the time between the 3 months before the EDC through delivery (67% 
of participating cases were employed; 72% of controls), and were from the following 
NBDPS sites: Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York 
and Texas.  We further excluded women with pregestational diabetes (7 NTD cases; 20 
controls), and 3 cases and 5 controls with a first degree family history of NTDs.   
Outcome assessment: We considered all NTDs combined as an outcome of interest as 
well as the following mutually exclusive NTD phenotypes: anencephaly and 
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craniorachischisis (BPA modification of ICD-9 114 740.0; 740.1), spina bifida (741.0; 741.9) 
and encephalocele (742.0).   
Exposure window:  We restricted the exposure period of interest to the 
periconceptional period, defined as one month preceding the EDC through the end of the first 
trimester.  
Adjustment for confounding: Covariates of interest included those considered in the 
literature to be moderate to strong risk factors for NTDs that may be associated with maternal 
occupational solvent exposure but are not on the causal pathway between exposure and NTD 
incidence.  The distribution of each covariate was examined and categorized appropriately.  
All covariates were included in adjusted models.  Table 9 presents the categorization of each 
covariate.  
  
Table 9.  Covariates for analyses of maternal solvent exposure and congenital anomalies 
Covariate Categorization 
Maternal age at delivery <20 yrs 
20-25 yrs (REF) 
26-35 yrs 
≥36 yrs 
Maternal race/ethnicity Non-Hispanic white (REF) 
Non-Hispanic black 
Hispanic 
Other  
Maternal education  <12 yrs 
12 yrs 
>12 yrs 
Smoking  During periconceptional period: 
Any 
None 
Folic acid supplementation During periconceptional period 
Little/no use (≤30 days) 
Some use (>30 days, <daily) 
Daily use (REF) 
Pre-pregnancy BMI Categorized according to NIH standard, with 
overweight and obese categories combined: 
Thin/normal weight (<25) (REF) 
Overweight (25 ≤ BMI <30) 
Obese (≥30)  
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Descriptive analysis: Data analysis began with standard variable description, data 
cleaning, variable (re)coding, and univariate and bivariate graphical and tabular analyses for 
all outcome and exposure variables as well as covariates of interest.  Disjoint indicator 
variables were constructed for categorical variables not meeting the assumption of linearity 
on the log scale.  The amount of missing data was evaluated for each variable; no variable 
was missing ≥5% of the total sample. A series of pairwise associations between exposures, 
outcome of interest, and covariates were examined to gain familiarity with the underlying 
data structure, to examine the strength and pattern of associations between variables, and to 
evaluate correlation between primary exposures and covariates.   
The crude association between exposure to any solvent and NTDs was stratified by 
each covariate of interest to assess effect measure modification using the Breslow-Day test 
for homogeneity (a priori α-level = 0.20).  No effect measure modifying covariates were 
identified.   
Modeling strategy:  Three sets of models were conducted for all NTDs combined 
using unconditional logistic regression.  Three additional sets of models were conducted for 
each series of component phenotypes (anencephaly, spina bifida, encephalocele) using 
polytomous logistic regression (PLR).  In the first set of models, we estimated unadjusted 
odds ratios (OR) and 95% confidence intervals (CI) to examine the association between 
exposure to each solvent class and all NTDs combined and component phenotypes.  In the 
second set of models, we estimated the independent effects of each solvent class by 
simultaneously including terms for each class in the models.  The final set of models 
included terms for each solvent class as well as for the following maternal characteristics 
reported during the maternal interview: age at delivery, race/ethnicity, education, pre-
 49
pregnancy body mass index, folic acid supplement use, and smoking.  Within each PLR 
model, we evaluated heterogeneity in the estimated exposure effects across component 
phenotypes using likelihood ratio tests (alpha-level = 0.20).115   
To account for the varying levels of estimated exposure probability in the exposure 
assessment, we repeated the primary exposure-defect analyses restricting the exposed group 
to women with at least one job with an estimated probability of exposure greater than or 
equal to 10% for any individual solvent within each solvent class.  This strategy was used to 
sharpen the exposure contrast by excluding women less likely to be exposed.  We also 
repeated analyses restricting all cases to only those with an isolated NTD, since cases of 
isolated congenital anomalies may differ etiologically from those presenting with multiple 
defects.    
Beta-estimates from the logistic models estimated the log-odds of having an NTD-
affected pregnancy among women estimated to be occupationally exposed to an organic 
solvent class during the periconceptional period of the index pregnancy, adjusting for all 
other covariates in the model. 
Effect size calculation: A priori effect size calculations were performed assuming 500 
NTD cases and 3000 controls for a range of distribution of exposure to solvents among all 
NBDPS participants presented in Table 8.  All effect size calculations were performed 
assuming an alpha-level of 0.05, 80 percent power, and unadjusted dichotomous exposure 
contrasts.  Table 10 presents the smallest detectable OR for all OFCs and a range of solvent 
exposure prevalence.   
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Table 10. Preliminary effect size calculations, NTDs. 
Exposure  
prevalence (%) 
NTD cases 
(n≈500) 
Controls 
(n≈3000) 
Minimum 
detectable OR 
1.0 5 30 2.8 
2.0 10 60 2.2 
5.0 25 150 1.7 
8.0 40 240 1.6 
10.0 50 3000 1.5 
 
This analysis had 80% power to detect an OR of approximately 1.6 for the association 
between estimated exposure to “any solvent” during the periconceptional period (observed 
prevalence ~ 8% among controls) and all NTDs combined.  Actual estimable effect sizes 
were likely larger given loss of sample size due to sample restrictions, missing data, and 
multivariate adjustment.   
3.4.3  Analytic plan for Aim 3: Solvent exposure and OFCs 
Aim 3 was to estimate the effect of maternal occupational solvent exposure during 
pregnancy on the prevalence of orofacial clefts.  Most features of the analytic framework and 
approach to data analysis (exposure window, adjustment for confounding, descriptive 
analysis, and modeling strategy) were the same as described for Aim 2 (NTDs).  Therefore 
we describe only the differences below.  
Study population: The study population included employed mothers of cases of OFCs 
(n=1249) and non-malformed controls (n=2997) delivered between 01 October 1997 and 31 
December 2002.   These mothers had participated in the NBDPS interview, reported having 
at least one job during the time between the 3 months before the EDC through delivery (67% 
of participating cases were employed; 72% of controls), and were from the following 
NBDPS sites: Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York 
and Texas.  We further excluded women with pregestational diabetes (17 OFC cases; 20 
controls), and 69 cases and 8 controls with a first degree family history of OFCs.   
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Outcome assessment: We considered all OFCs combined as an outcome of interest as 
well as the following two mutually exclusive OFC phenotypes: cleft palate alone (749.0 
except 749.08) and cleft lip with or without cleft palate (749.1 except 749.19; 749.2).    
Effect size calculation: A priori effect size calculations were performed assuming 
1250 OFC cases and 3000 controls for a range of distribution of exposure to solvents among 
all NBDPS participants presented in Table 8.  All effect size calculations were performed 
assuming an alpha-level of 0.05, 80 percent power, and unadjusted dichotomous exposure 
contrasts.  Table 11 presents the smallest detectable OR for all OFCs and a range of solvent 
exposure prevalence.   
 
Table 11. Preliminary effect size calculations, OFCs. 
Exposure  
prevalence (%) 
OFC cases 
(n≈1250) 
Controls 
(n≈3000) 
Minimum 
detectable OR 
1.0 12.5 30 2.2 
2.0 25 60 1.8 
5.0 62.5 150 1.5 
8.0 100 240 1.4 
10.0 125 3000 1.3 
 
This analysis had 80% power to detect an OR of approximately 1.4 for the association 
between estimated exposure to “any solvent” during the periconceptional period (observed 
prevalence ~ 8% among controls) and all OFCs combined.   
3.5  Approvals 
The Public Health Institutional Review Board (IRB) at the University of North 
Carolina, Chapel Hill, determined that this dissertation does not constitute human subjects 
research as defined by federal regulations and therefore does not require IRB approval (study 
no. 08-1875; 10/31/2008).   
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The National Birth Defects Prevention Study is approved by the IRB of the CDC as 
well as by all participating CBDRP.  Additional approvals for this project required by the 
NBDPS, including approval of the research proposal by the internal Data Sharing 
Committee, data use agreement, and declaration of confidentiality and data security have all 
been satisfactorily met.  
 CHAPTER 4: RESULTS 
4.1  Prevalence of solvent exposure during pregnancy  
As originally proposed, Specific Aim 1 of this dissertation was to evaluate variability 
in occupational organic solvent exposure prevalence across different time periods of 
pregnancy.  The results of the associated analyses are summarized below in Table 12.  
Approximately 8.7% of mothers were considered to be occupationally exposed to one or 
more organic solvents “anytime” during pregnancy (i.e., between 3 months before the EDC 
through delivery).  Between different time windows, the exposure prevalence varied slightly 
from 6.2% in the third trimester to 8.0% in the first trimester and before conception.  The 
series of low OTW ratios (close to 1.0) across all time windows suggests little-to-no within-
woman variability in estimated exposure.  In other words, the same women were considered 
exposed in each window.  The interpretation of low OTW ratios is that there would be little 
exposure misclassification introduced by an anytime-during-pregnancy measure of solvent 
exposure status in these data even if the biologically relevant critical window for exposure 
was a narrower time window like a particular trimester.  Kappa coefficients ranged from 0.77 
to 0.95, also indicating high concordance in exposure status across mutually exclusive time 
windows.   
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Table 12. Estimated occupational solvent exposure prevalence, exposure duration, and OTW 
ratios for different pregnancy time windows among employed mothers of controls (n=2,997), 
NBDPS, 1997-2002. 
 Anytime  BEFORE T1 T2 T3 
Exposure prevalence 
   Exposed    
   Unexposed 
   Unknown 
 
261 
2713 
23 
 
239 
2736 
22 
 
240 
2734 
23 
 
211 
2768 
18 
 
185 
2794 
18 
Percent exposed among all mothers 8.7% 8.0% 8.0% 7.0% 6.2% 
Length of time window (days) 
Duration of exposure among exposed 
   Mean 
   Min, Max 
388 
 
272 
29, 378 
90 
 
84 
2, 90 
90 
 
81 
2, 90 
90 
 
83 
4, 90 
118 
 
75 
2, 108 
OTW ratio -- 1.09 1.09 1.24 1.41 
BEFORE, conception – 3 months; T1, first trimester; T2, second trimester; T3, third trimester; OTW, overall-to-window 
 
Originally, we hypothesized that we would observe variability in solvent exposure 
status over the course of pregnancy, and thus we intended to conduct additional sensitivity 
analyses to empirically demonstrate the effect of misclassifying exposure during the 
biologically relevant critical window for congenital anomalies.  In actuality, very little 
variability in exposure status over the course of pregnancy was observed in these data and 
therefore further analyses were not conducted.  
We hypothesized that an explanation for this lack of variability in estimated exposure 
status over the course of pregnancy was because exposure status was based on employment 
histories, which must have likewise been very stable (i.e. no variability in employment status 
or occupation) over the course of pregnancy.  Using the same strategy of linking job dates 
with pregnancy dates described earlier (Section 3.3.3), we examined the assumption that 
employment status was constant throughout pregnancy (i.e. women who worked anytime 
during pregnancy worked for all of their pregnancy).   
Manuscript 1 (Section 4.2) is the resulting brief report that presents the rationale, 
methods and results of our examination of the prevalence and patterns of employment before 
and during pregnancy among mothers of controls in the NBDPS, as well as a discussion of 
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the implications of our findings for future studies of prenatal exposures and adverse 
pregnancy outcomes.  
4.2  Manuscript 1: Patterns of maternal employment before and during pregnancy  
4.2.1  Introduction 
In epidemiologic studies of prenatal exposures and pregnancy outcomes, exposure 
variability over the course of pregnancy is important to consider since the timing of the 
exposure frequently determines the nature and magnitude of its effect.108,116  Thalidomide, for 
example, is associated with a spectrum of human embryopathies depending on the timing of 
exposure: 20-23 days after conception causes external ear malformations, whereas exposure 
24-31 and 27-33 days after conception causes upper and lower limb defects, respectively.117  
Another example is tobacco use, which is more strongly associated with restricted fetal 
growth as gestational age increases, such that no effect on fetal growth is observed among 
women who stop smoking earlier in pregnancy.118  Identifying critical windows for prenatal 
exposures can advance hypotheses about biologic mechanisms, inform exposure assessment, 
and help identify susceptible populations for public health intervention.  In practice, this 
pursuit requires use of time-dependent exposure measures that capture exposure variability 
over the course of pregnancy.    
Collection of timing-specific occupational information (e.g., by month of pregnancy) 
is resource intensive and particularly challenging in retrospective studies.  Often, studies of 
maternal employment obtain only one measure of employment status, such as employment at 
delivery or “anytime” during pregnancy, and assume that employment status is constant 
throughout pregnancy.  If employment status is not constant, this practice can lead to biased 
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measures of association between employment and adverse pregnancy outcomes due to 
misclassification of employment during the critical window of exposure.16,107   
There is little evidence in the literature to support – or refute – the assumption that 
maternal employment status is constant throughout pregnancy.  Published reports on patterns 
of maternal employment have generally focused on duration of employment (What 
proportion of employed women work into their second [third]  trimester?) rather than 
changes in employment status (What proportion of women start [stop, remain] working 
during pregnancy?).15,119  Our objective was to explore the latter questions.  In the following 
brief report, we present a description of the prevalence and patterns of maternal employment 
before and during pregnancy in a population-based sample of mothers of infants delivered 
between 1997 and 2005 who participated in the National Birth Defects Prevention Study 
(NBDPS). 
4.2.2  Methods 
The NBDPS is an ongoing case-control study of risk factors for structural congenital 
anomalies in the United States.109  The study population for this analysis consisted of 
mothers of live born infants with no major birth defects (controls) delivered between October 
1997 and December 2005 who were randomly selected from birth certificates or hospital 
delivery records in 10 participating states (Arkansas, California, Georgia, Iowa, 
Massachusetts, New Jersey, New York, North Carolina, Texas and Utah).  Approximately 
66% (n=6,807) of eligible mothers participated in the NBDPS during this time. 
Mothers were interviewed in English or Spanish using a structured telephone 
questionnaire within 24 months after delivery; median infant age at interview was 8 months.  
During the interview, mothers were asked whether they had been employed at any time 
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between the three months before they became pregnant and their infant’s date of birth.  
Employment was defined as any compensated or volunteer work lasting at least one month, 
including military service.  Dates of employment for up to six jobs were obtained and 
recorded as the month and year that each job started and ended.   
We developed an algorithm to assign complete job dates consisting of day, month and 
year.  First, each job was assumed to begin on the first day of the reported starting month and 
end on the last day of the reported ending month.  Second, for mothers with multiple jobs, 
jobs overlapping by exactly one month were assumed to have been held consecutively and 
job dates were further modified such that the overlapping month was approximately evenly 
divided between jobs (i.e., Job 1 was modified to end on mm/14/yy and Job 2 was modified 
to start on mm/15/yy).  Any jobs overlapping by more than one month were assumed to have 
been held concurrently and job dates were not further modified.  
Pregnancy dates reported during the interview included the date of the last menstrual 
period (LMP) and the infant’s date of birth (DOB).  The estimated date of conception (EDC) 
was calculated as the DOB-266 days, or LMP+14 days if the DOB was missing.  We 
constructed four mutually exclusive pregnancy time windows: (1) before pregnancy, defined 
as 90 days preceding the EDC; (2) the first trimester, defined as the time between the EDC 
and 89 days after the EDC; (3) the second trimester, defined as the time between 90 days 
after the EDC and 179 days after the EDC (or the DOB, whichever came first); and (4) the 
third trimester, defined as the time between 180 days after the EDC and the DOB.   
We considered a mother to be employed in a given time window if she worked at 
least one job during any portion of that window.  We calculated the prevalence of maternal 
employment anytime before and during pregnancy and for each time window of interest.  
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Among mothers employed anytime before and during pregnancy, we determined the 
proportion who experienced a change in employment status during pregnancy (e.g., from 
unemployed to employed) and the proportion who remained employed for the entire duration 
of their pregnancy.  
Of the 6,807 eligible mothers, 98 were excluded from all analyses because they did 
not provide any employment information during the interview.  We further excluded 96 
women from all time window-specific analyses: 2 women who reported having worked but 
did not provide any additional employment information, 63 women with missing 
employment dates that could not be reconciled by manual review, and 31 women whose 
reported employment dates were inconsistent with the time period of interest (i.e., between 3 
months before conception and delivery).   
4.2.3  Results 
Seventy-two percent of women (n=4,832) reported having been employed anytime 
before or during pregnancy (Table 13).  The highest prevalence of employment was observed 
during the first trimester (67.8%) and the lowest during the third trimester (58.7%), 
indicating that fewer women were employed later in pregnancy.   
Further examination of within-woman patterns of employment among mothers 
employed anytime before and during pregnancy revealed that approximately 75% (n=3,569) 
of women were consistently employed across all time windows (Table 14).  The remaining 
women experienced a change in employment status at some point during pregnancy.  Among 
these women, the most common patterns represented women employed before pregnancy 
who ceased employment during the first or second trimester and remained unemployed 
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thereafter (n=710; 15.0%).  It was less common for women to be unemployed before 
conception and initiate employment sometime during pregnancy (n=344; 7.3%).    
 
Table 13. Prevalence of employment across time windows of pregnancy among mothers of 
non-malformed liveborn controls, National Birth Defects Prevention Study, 1997-2005 
(n=6,709).  
  
Pregnancy time windows 
Anytimea 
 
Before 
conceptionb 
 
First  
trimester 
 
Second 
trimester 
 
Third  
trimester 
n (%) 
 
n (%c) 
 
n (%c) 
 
n (%c) 
 
n (%c) 
 
4832 
 
 
(72.0) 
  
4392 
 
(66.4) 
  
4482 
 
(67.8) 
  
4262 
 
(64.4) 
  
3870 
 
(58.7) 
a Defined as the 3 months before the estimated conception date through the infant’s date of birth. 
b
 Defined as the 3 months before the estimated conception date. 
c
 Window-specific estimates are based on all mothers who reported working anytime during pregnancy for 
whom information was available about the timing of all jobs relative to each pregnancy time window (n=4736), 
plus non-employed mothers (n=1877), with the exception of the third trimester, for which mothers who 
delivered in the second trimester were also excluded (n=21).   
 
 
 
 
Table 14. Patterns of employment status before and during pregnancy among mothers of non-
malformed liveborn controls, in descending order by frequency, National Birth Defects 
Prevention Study, 1997-2005. 
Time windows 
(x = employed during window) 
Number of 
women 
Percent of 
employed 
women only 
(n=4736) a 
Percent of 
all women 
(n=6709) Before 
conceptionb 
First 
trimester 
Second 
trimester 
Third 
trimester 
 
x x x x 3,569 75.4 53.2 
x x x 
 
370 7.8 5.5 
x x 
  
340 7.2 5.1 
 
x x x 152 3.2 2.3 
  
x x 110 2.3 1.6 
x 
   
98 2.1 1.5 
 
x x 
 
39 0.8 0.6 
   
x 24 0.5 0.4 
Other patternsc 34 
  
a All mothers who reported working anytime during pregnancy for whom information was available about the 
timing of all jobs relative to each pregnancy time window 
b
 Defined as the 3 months before the estimated date of conception. 
c
 Other observed patterns: first trimester only (n=10); second trimester only (n=9); all windows except first 
trimester (n=13); all windows except second trimester (n=2). 
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4.2.4  Discussion 
Recent data on the prevalence and patterns of maternal employment during pregnancy 
are limited.  The U.S. Census Bureau reports that 67% of women worked for pay at some 
point during the pregnancy leading to their first birth between 2001 and 2003, and that 87% 
of these employed women worked into their last trimester.15  In contrast to the Census report, 
our study included both primi- and multiparous women who worked with or without pay for 
at least one month duration.  Despite differences in design, our results were generally 
consistent with the Census report.  We found that 72% of women worked anytime before and 
during pregnancy, and that approximately 80% worked into their last trimester.  Unique to 
our study, we further examined patterns of employment status, revealing that three fourths of 
employed women were consistently employed in one or more jobs before pregnancy through 
their last trimester, whereas one fourth of women changed employment status during 
pregnancy.  Among women who changed employment status, more than twice as many were 
employed before pregnancy and later stopped working (15%) than started working after their 
pregnancy began (~7%).   
The fact that employment status is not constant over the course of pregnancy for a 
large proportion of women (25%) means that single measures of employment status may not 
accurately characterize maternal occupational exposure occurring in different time windows 
during pregnancy.  Use of anytime-during-pregnancy measures will include women 
employed during irrelevant time periods and introduce misclassification that, in general, will 
bias effect measure estimates toward the null.16,107  The effect of this misclassification could 
be magnified in a study in which the exposure of interest is not employment per se but rather 
some other related factor like job title or chemical exposure that further varies within levels 
of employment status.  Results from studies using an anytime-during-pregnancy measure of 
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employment status should therefore be interpreted cautiously as null findings may reflect 
attenuation due to exposure misclassification rather than evidence of no effect.  However, 
since 95% of women who were employed anytime before and during pregnancy were 
employed in the first trimester, misclassification resulting from use of an anytime-during-
pregnancy measure may be less of a concern for studies in which the critical window is 
known to be around the time of conception or early pregnancy. 
Use of a single-point-in-time measure of employment status, such as “employment at 
delivery,” will likewise introduce exposure misclassification if the point in time does not 
correspond to the critical window.  Consider a study in which the biologically relevant 
window is shortly after conception, but employment information is limited to employment 
status at the time of delivery.  Given the employment patterns observed in our sample, this 
hypothetical study would incorrectly classify 16% of employed women as non-employed 
(i.e., women employed in the first trimester but not the third) and 3% of non-employed 
women as employed (i.e., women employed in the third trimester but not the first).  This 
potential for misclassification may be of greater concern in studies that obtain employment 
information from birth certificates, on which it’s often unclear whether employment 
corresponds to usual occupation, most recent occupation, current occupation at delivery or 
occupation at some other time before or during pregnancy.  Studies investigating the validity 
of parental occupation information on birth certificates suggest that employment is generally 
underreported.120,121  In one such study by Brender et al. (2002) of nearly 650 women in 
Texas who participated in NBDPS,121 approximately one third of women who reported via 
interview that they were employed during the first trimester were documented on the birth 
certificate as unemployed (JD Brender, written communication of unpublished data, 2/2011).  
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A number of factors make the NBDPS sample of controls a useful framework in 
which to explore patterns of maternal employment during pregnancy.  Our population-based 
sample of nearly 7,000 primi- and multiparous women was geographically and 
demographically diverse and spanned over 8 recent years.  Detailed occupational histories 
were carefully collected via interview, allowing for employment status to be determined for 
different time periods before and during pregnancy.  Additionally, because mothers were 
interviewed soon after delivery, we minimized the potential for recall error in employment 
dates.   
Despite the short recall period, error in self-reported employment dates or in our 
assignment of complete job dates may have resulted in misclassification of employment 
status in any of the four pregnancy time windows, thereby influencing the observed patterns 
of employment.  Another limitation of our study is that mothers participating as controls in 
the NBDPS may not be representative of other populations of women with different 
distributions of factors related to employment.  Participants were all mothers of live born 
non-malformed infants, and were more likely than women in their base population to be 
white and have more years of education.110  Though participants were employed in a wide 
variety of occupations,122 other differences in demographic, behavioral and obstetric factors 
associated with self-selection into (and out of) employment likely influenced the prevalence 
and patterns of employment observed in our study, and thus the ability to generalize our 
findings to other populations of pregnant women.123,124   
In conclusion, we found that employment status is not constant over the course of 
pregnancy for a substantial proportion of women.  Our findings underscore the importance of 
using a time-dependent assessment of employment status that corresponds as closely as 
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possible to the biologically relevant critical window to reduce exposure misclassification.  
We encourage investigators to consider the impact of within-woman variability in 
employment status in the design and analysis of future studies of maternal employment and 
adverse pregnancy outcomes.   
4.3  Manuscript 2: Maternal occupational exposure to organic solvents during early 
pregnancy and selected congenital anomalies 
4.3.1  Introduction 
Organic solvents are a group of volatile carbon-based chemicals common in 
occupational settings due to their wide application as cleaners, degreasers and reagents in 
varied industrial processes.  These solvents are commercially available in thousands of 
industrial formulations and are used in the production of paints, adhesives, inks and dyes, dry 
cleaning solutions, pesticides, fuels, cosmetics and pharmaceuticals.  Millions of workers in 
the United States are potentially exposed to organic solvents,125 but the current prevalence of 
occupational exposure among pregnant women is unknown.   
A number of organic solvents are recognized reproductive toxins, although the 
specific mechanisms by which they exert developmental toxicity and teratogenesis in 
particular are not well understood.1,13  One leading hypothesis is that these compounds 
produce oxidative stress (OS) to which early embryonic development is strongly 
susceptible.24,25  The capacity to induce embryonic OS has been demonstrated for several 
organic solvents including benzene, carbon tetrachloride, chloroform, methylene chloride, 
perchloroethylene and trichloroethylene.30,31  Animal models of ethanol-induced OS suggest 
that OS causes alterations in gene expression and interferes with normal cellular activity of 
the neural crest cell population, ultimately leading to brain and facial abnormalities.27,28,126,127  
Neural tube defects (NTDs) and orofacial clefts (OFCs) are two major groups of congenital 
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anomalies thought to result from abnormal embryological development of neural crest cells, 
and thus may be particularly susceptible to oxidative stressors.   
Though a number of epidemiologic studies have investigated the potential association 
between maternal occupational exposure to organic solvents and NTDs or OFCs, inconsistent 
results between studies are difficult to interpret given important limitations in study design 
and exposure assessment.80,94-97,99,100,105,106  For example, some studies have combined major 
malformations that are embryologically or pathogenetically distinct into one outcome group 
of interest; this practice may dilute effect measure estimates by masking etiological 
heterogeneity between phenotypes.128  Another limitation common to retrospective studies is 
exclusive use of job title (e.g., “nurse”) as a surrogate for exposure; this strategy is less able 
to discriminate exposure profiles within groups of occupation and industry than more 
detailed assessments incorporating expert review of occupational histories.101  The resulting 
bias is of special concern in studies where the overall prevalence of exposure is low, since 
misclassification of even a few unexposed individuals as exposed can lead to substantial 
attenuation of observed effect estimates.129  
Given the prevalent use of organic solvents in the workplace and their suspected 
capacity to exert developmental toxicity in humans, the potential effects in offspring among 
women exposed during pregnancy warrant further investigation in studies designed to 
minimize both exposure and outcome misclassification.  We investigated the association 
between maternal occupational exposure to organic solvents during early pregnancy and the 
prevalence of NTDs and OFCs in a large, population-based sample of women for whom 
exposure was assigned using a comprehensive job-exposure database and expert review of 
self-reported occupational histories. 
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4.3.2  Methods 
The National Birth Defects Prevention Study (NBDPS) is an ongoing, multi-site, 
population-based case-control study designed to investigate a range of risk factors for major 
congenital anomalies.109  Participating birth defect surveillance programs identified cases of 
NTDs and OFCs among live births, fetal deaths greater than 20 weeks gestation, and 
prenatally diagnosed elective terminations.  Non-malformed live birth controls were 
randomly selected using either birth certificates or hospital records from the same base 
population as cases in each state.  Mothers of cases and controls were interviewed by 
telephone in either English or Spanish up to 24 months after the date of delivery.  Using 
pregnancy calendars to aid recall, interviewers elicited information about demographic, 
environmental, nutritional, behavioral and clinical factors before and during pregnancy.  The 
NBDPS is approved by the institutional review boards of the Centers for Disease Control and 
Prevention and all participating sites.   
Our study population included employed mothers of cases of NTDs (n=521), OFCs 
(n=1249) and non-malformed controls (n=2997) delivered between 01 October 1997 and 31 
December 2002.   These mothers had participated in the NBDPS interview (71% of cases 
participated; 68% of controls), reported having at least one job during the time between the 3 
months before the estimated date of conception (EDC) through delivery (67% of 
participating cases were employed; 72% of controls), and were from the following NBDPS 
sites: Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York and Texas.  
The average infant age at interview was 10 months for NTD cases, 10 months for OFC cases, 
and 8 months for controls.   
We excluded women with pregestational diabetes (7 NTD cases; 17 OFC cases; 20 
controls).  For analyses of NTDs, we further excluded 3 cases and 5 controls with a first 
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degree family history of NTDs;   for analyses of OFCs, we excluded 69 cases and 8 controls 
with a positive family history.   
 
Outcome classification   
Clinical geneticists at each site performed a standardized review of abstracted 
medical records to confirm eligibility of cases for the NBDPS.111  Eligible cases were then 
further classified by NBDPS clinicians as having one isolated major congenital anomaly, 
multiple major anomalies, or a pattern of anomalies representing a complex developmental 
syndrome.  Cases with anomalies of known etiology (e.g., single-gene disorders and 
chromosomal abnormalities) were excluded from the NBDPS.  Neural tube defects were 
further classified by major component phenotype: anencephaly and craniorachischisis (BPA 
modification of ICD-9 114 740.0; 740.1), spina bifida (741.0; 741.9) and encephalocele 
(742.0).  Orofacial clefts were further classified into two component phenotypes: cleft palate 
alone (749.0 except 749.08) and cleft lip with or without cleft palate (749.1 except 749.19; 
749.2).    
 
Exposure characterization   
The occupational history section of the maternal interview identified mothers who 
were employed for at least one month duration from three months preceding the EDC 
through the end of pregnancy.  Employment was defined as compensated, volunteer or 
military service, including part-time work and work performed at home.  For each reported 
job, mothers were asked about the employer, job title, primary tasks and duties, chemicals 
and machines handled on the job, dates of employment, and hours and days worked per 
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week; up to 6 jobs could be recorded.  Jobs were then coded by occupation and industry 
according to the Standard Occupational Classification Manual (2000)112 and North American 
Industry Classification System (1997),113 and assessed for exposure to 10 organic solvents 
including 3 aromatic solvents (benzene, xylene, toluene), 6 chlorinated solvents (carbon 
tetrachloride, chloroform, methylene chloride, perchloroethylene, trichloroethylene, 1,1,1-
trichloroethane), and the petroleum-based mixture Stoddard solvent (also known as mineral 
or white spirits).  Comprehensive era-specific (1997-1999; 2000-2002) and solvent-specific 
job-exposure databases were developed for NBDPS by a team of occupational 
epidemiologists and industrial hygienists (IH).  These job-exposure databases, based on 
extensive literature reviews of published papers reporting direct measurements and 
determinants of exposure for various occupations and industries, were then used in 
combination with IH review of self-reported job information to estimate the probability of 
exposure for each reported job.  Probability was defined as the likelihood that a specific job 
within an industry within a given era had any exposure to the solvent; each job was assigned 
one of the following categories for exposure probability: 0 (unexposed), <10%, 10-49%, 50-
89% and ≥90%.   
Using self-reported job dates, we restricted the exposure period of interest to the 
periconceptional period, defined as one month preceding the EDC through the end of the first 
trimester.  The periconceptional period corresponds to the critical window in embryologic 
development during which NTDs and OFCs are thought to occur.116  Thus, for each solvent, 
a mother was considered exposed if any of her jobs during the periconceptional period were 
rated as exposed (i.e., probability of exposure > 0 for any job).  She was considered 
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unexposed if she did not have a job during the perioconceptional period or if all her jobs 
during that time were rated as unexposed (i.e., exposure probability = 0 for all jobs).   
 
Statistical analysis 
Using the dichotomous exposure variable previously described (exposed/unexposed), 
we examined the prevalence of estimated exposure to each solvent and solvent class 
(aromatic; chlorinated; Stoddard solvent) among mothers by case-control status.  We then 
explored correlation in assigned exposure status within and between solvent classes among 
all exposed mothers of controls to determine the best modeling strategy.   Exposure status 
was strongly correlated between individual solvents within solvent class.   For example, 98% 
of women exposed to methylene chloride were also exposed to trichloroethane.  Exposure 
correlation between solvent classes was substantially lower than within classes.  Given strong 
exposure correlation among individual solvents within solvent class, in multivariable 
modeling analyses we considered exposure to solvent class only.   
Three sets of models were conducted for each composite defect group (e.g., NTDs) 
using unconditional logistic regression, and for each series of component phenotypes (e.g., 
anencephaly, spina bifida, encephalocele) using polytomous logistic regression (PLR).  In the 
first set of models, we estimated unadjusted odds ratios (OR) and 95% confidence intervals 
(CI) to examine the association between exposure to each solvent class and each composite 
or component outcome.  In the second set of models, we estimated the independent effects of 
each solvent class by simultaneously including terms for each class in the models.  The final 
set of models included terms for each solvent class as well as for the following maternal 
characteristics reported during the maternal interview: age at delivery, race/ethnicity, 
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education, pre-pregnancy body mass index, folic acid supplement use, and smoking.  Within 
each PLR model, we evaluated heterogeneity in the estimated exposure effects across 
component phenotypes using likelihood ratio tests (alpha-level = 0.20).115   
To account for the varying levels of estimated exposure probability in the exposure 
assessment, we repeated the primary exposure-defect analyses restricting the exposed group 
to women with at least one job with an estimated probability of exposure greater than or 
equal to 10% for any individual solvent within each solvent class.  This strategy was used to 
sharpen the exposure contrast by excluding women less likely to be exposed.  We also 
repeated analyses restricting all cases to only those with an isolated NTD or OFC, since cases 
of isolated congenital anomalies may differ etiologically from those presenting with multiple 
defects.    
4.3.3  Results 
Analyses consisted of mothers of 511 NTD cases (and 2972 corresponding controls) 
and 1163 OFC cases (and 2969 corresponding controls) who were employed for at least one 
month duration from three months preceding the EDC through the date of infant delivery.  
Table 15 summarizes the distribution of maternal characteristics in this sample.   
Among all women rated as exposed to any solvent during the periconceptional period, 
approximately 85% were exposed to more than one solvent (data not shown).  The 
prevalence of estimated occupational exposure to any organic solvent during the 
periconceptional period was 8.2% among mothers of controls, 13.1% among mothers of all 
NTD cases and 9.6% among mothers of all OFC cases (Table 16).  The prevalence of any 
solvent exposure was higher among mothers of spina bifida (14.4%) and encephalocele 
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(16.4%) cases than anencephaly (8.4%); exposure prevalence did not vary across OFC 
component phenotypes.   
Across all case and control mothers, exposure prevalence was highest for the 
chlorinated solvent class (e.g., 6.9% among controls) and lowest for the aromatic solvent 
class (e.g., 2.0% among controls).  The distribution of probability of exposure also varied 
between solvent classes (data not shown).  For Stoddard solvent and aromatic solvents, over 
90% of exposed mothers worked in at least one job with an estimated exposure probability of 
at least 10%.  However, for chlorinated solvents, only 30% of exposed mothers had an 
exposure probability of at least 10%.  Within solvent class, exposure prevalence to individual 
solvents varied considerably.  For example, within the chlorinated solvent class, exposure 
prevalence among controls ranged from 0.3% for carbon tetrachloride to 6.0% for both 
methylene chloride and trichloroethane.   
In analyses of neural tube defects (Table 17), we observed a positive association with 
maternal exposure to chlorinated solvents (adjusted OR=1.96 [95%CI = 1.34, 2.87]) but not 
with aromatic solvents (0.75 [0.36, 1.55]) or Stoddard solvent (0.63 [0.33, 1.23]) after 
adjusting for solvent class and potential confounders.  The magnitude of the effect measure 
was stronger for spina bifida (2.26 [1.44, 3.53]) and encephalocele (2.22 [0.84, 5.82]) than 
for anencephaly (1.25 [0.58, 2.71]).  However, these observed differences in effect across 
NTD phenotypes were not statistically significant (p=0.36).  Results were nearly identical 
when restricting cases to only those with an isolated NTD (n=448; 88%).  In the secondary 
analysis restricting the exposed group to women with an estimated exposure probability 
≥10%, results were similar to the observed effect measure estimates for all exposed women 
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for both Stoddard and aromatic solvents.  For chlorinated solvents, the unadjusted OR was 
closer to the null and considerably less precise (1.32 [0.77, 2.29]; 16 exposed cases). 
In analyses of orofacial clefts (Table 18), we did not observe a strong association with 
maternal exposure to any solvent class.  Effect measure point estimates for Stoddard solvent 
were slightly elevated in general, but the associated confidence intervals were wide.  
Restriction to isolated cases of OFCs (n=997; 86%) as well as to women with an estimated 
exposure probability ≥10% yielded similar results.   
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Table 15. Distribution of select demographic and behavioral factors among employeda 
mothers of cases of neural tube defects, orofacial clefts and non-malformed controls, 
National Birth Defects Prevention Study, United States, 1997-2002. 
       
 
Covariate 
Controlsb 
(n = 2977) 
All NTDs 
(n = 511) 
All OFCs 
(n= 1163) 
 n (%) n (%) n (%) 
Maternal age at delivery       
   <20 years 240 (8.1) 47 (9.2) 109 (9.4) 
   20-25 years (R) 798 (26.8) 140 (27.4) 339 (29.2) 
   26-35 years 1600 (53.8) 259 (50.7) 578 (49.7) 
   ≥ 36 years 339 (11.4) 65 (12.7) 137 (11.8) 
Maternal race/ethnicity       
   White, non-Hispanic (R) 1929 (65.0) 304 (59.5) 807 (69.5) 
   Black, non-Hispanic 376 (12.7) 58 (11.4) 74 (6.4) 
   Hispanic 525 (17.7) 123 (24.1) 214 (18.4) 
   Other 140 (4.7) 26 (5.1) 67 (5.8) 
   Missing 7  0  1  
Maternal education       
   <12 years 294 (9.9) 72 (14.1) 152 (13.1) 
   12 years 736 (24.8) 153 (30.0) 306 (26.3) 
   >12 years (R) 1942 (65.3) 285 (55.9) 704 (60.6) 
   Missing 5  1  1  
Pre-pregnancy BMI       
   Thin/normal weight (<25) (R) 1824 (62.6) 272 (55.2) 698 (61.5) 
   Overweight (25 ≤ BMI <30) 662 (22.7) 105 (21.3) 246 (21.7) 
   Obese (≥30) 430 (14.8) 116 (23.5) 191 (16.8) 
    Missing 61  18  28  
Folic acid supplement usec       
   Little/no use (≤30 days) 638 (21.8) 123 (34.4) 251 (21.8) 
   Some use (>30 days, <daily) 1498 (51.5) 243 (48.2) 593 (51.6) 
   Daily use (R) 795 (27.1) 138 (27.4) 306 (26.6) 
   Missing 46  7  13  
Maternal smokingc       
   Any 607 (20.4) 95 (18.6) 300 (25.8) 
   None (R) 2370 (79.6) 416 (81.4) 863 (74.2) 
NTD, neural tube defect; OFC, orofacial cleft; BMI, body mass index; R, referent category 
a Employed in at least one job for at least one month duration between three months preceding the estimated 
date of conception through the date of infant delivery.   
b
 The control group for analyses of neural tube defects further excluded 5 controls with a family of history of 
neural tube defects; the control group for analyses of orofacial clefts further excluded 8 controls with a family 
history of orofacial clefts. 
c During the periconceptional period, from one month preceding the estimated date of conception through the 
first three months of pregnancy.  
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Table 16. Prevalence of estimated occupational exposure to organic solvents during the periconceptional perioda among employed 
mothers of cases of neural tube defects, orofacial clefts and non-malformed controls, National Birth Defects Prevention Study, United 
States, 1997-2002. 
Chlorinated solvents 205 (6.9)  61 (12.1) 11 (8.4) 40 (12.8) 10 (16.4)  88 (7.6) 29 (7.0) 59 (8.0) 
   Carbon tetrachloride 8 (0.3)  0  0  0  0   3 (0.3) 2 (0.5) 1 (0.1) 
   Chloroform 84 (2.8)  18 (3.5) 2 (1.5) 11 (3.5) 5 (8.2)  34 (2.9) 11 (2.7) 23 (3.1) 
   Methylene chloride 179 (6.0)  56 (11.0) 10 (7.5) 37 (11.8) 9 (14.8)  80 (6.9) 27 (6.5) 53 (7.1) 
   Perchloroethylene 111 (3.7)  27 (5.3) 5 (3.7) 16 (5.1) 6 (9.8)  44 (3.8) 15 (3.6) 29 (3.9) 
   Trichloroethane 177 (6.0)  57 (11.2) 11 (8.2) 37 (11.8) 9 (14.8)  80 (6.9) 26 (6.3) 54 (7.2) 
   Trichloroethylene 97 (3.3)  23 (4.5) 3 (2.2) 15 (4.8) 5 (8.2)  39 (3.4) 12 (2.9) 27 (3.6) 
Stoddard solvent 79 (2.7)  18 (3.5) 4 (3.0) 11 (3.5) 3 (4.9)  41 (3.5) 16 (3.9) 25 (3.4) 
NTD, neural tube defect; OFC, orofacial cleft 
a
 One month preceding the estimated date of conception through the end of the third month of pregnancy.   
b The control group for analyses of neural tube defects further excluded 5 controls with a family of history of neural tube defects; the control group for analyses 
of orofacial clefts further excluded 8 controls with a family history of orofacial clefts.   
                   
 
 
Controlsb 
(n = 2977) 
 All NTDs 
(n = 511) 
Anencephaly 
(N = 134) 
Spina bifida 
(n = 316) 
Encephalocele 
(n = 61) 
 All OFCs 
(n = 1163) 
Cleft palate 
(n = 414) 
Cleft lip ± 
cleft palate 
(n = 749) 
 n (%)  n (%) n (%) n (%) n (%)  n (%) n (%) n (%) 
Any solvent 242 (8.2)  66 (13.1) 11 (8.4) 45 (14.4) 10 (16.4)  111 (9.6) 39 (9.5) 72 (9.7) 
   Missing 23   7         9      
Aromatic solvents 60 (2.0)  11 (2.2) 3 (2.3) 6 (1.9) 2 (3.3)  24 (2.1) 10 (2.4) 14 (1.9) 
   Benzene 15 (0.5)  3 (0.6) 2 (1.5) 1 (0.3) 0   6 (0.5) 2 (0.5) 4 (0.5) 
   Toluene 58 (2.0)  11 (2.2) 3 (2.2) 6 (1.9) 2 (3.3)  22 (1.9) 9 (2.2) 13 (1.7) 
   Xylene 59 (2.0)  11 (2.2) 3 (2.2) 6 (1.9) 2 (3.3)  23 (2.0) 9 (2.2) 14 (1.9) 
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Table 17. Association between maternal occupational exposure during the periconceptional perioda to organic solvents and neural tube 
defects, National Birth Defects Prevention Study, United States, 1997-2002. 
 
      Any NTDb         Anencephalyc        Spina bifidac         Encephalocelec  
Solvent class OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) pd 
     
 Unadjusted    
Chlorinated 1.85 (1.37, 2.51) 1.23 (0.66, 2.33) 1.98 (1.38, 2.84) 2.64 (1.32, 5.28) 0.23 
Stoddard 1.35 (0.80, 2.28) 1.14 (0.41, 3.16) 1.34 (0.70, 2.54) 1.91 (0.59, 6.24) 0.81 
Aromatic 1.07 (0.56, 2.06) 1.13 (0.35, 3.65) 0.94 (0.40, 2.20) 1.66 (0.40, 6.96) 0.80 
     
 Adjusted for solvent class     
Chlorinated 2.02 (1.42, 2.88) 1.25 (0.59, 2.64) 2.30 (1.52, 3.48) 2.43 (1.03, 5.70) 0.29 
Stoddard 0.86 (0.47, 1.55) 0.99 (0.31, 3.20) 0.79 (0.38, 1.63) 1.00 (0.26, 3.90) 0.92 
Aromatic 0.72 (0.36, 1.44) 0.99 (0.28, 3.45) 0.59 (0.24, 1.45) 0.94 (0.20, 4.37) 0.76 
          
 Adjusted for solvent class and covariates e      
Chlorinated 1.96 (1.34, 2.87) 1.25 (0.58, 2.71) 2.26 (1.44, 3.53) 2.22 (0.84, 5.82) 0.36 
Stoddard 0.63 (0.33, 1.23) 0.66 (0.18, 2.43) 0.66 (0.31, 1.43) 0.38 (0.04, 3.21) 0.87 
Aromatic 0.75 (0.36, 1.55) 1.12 (0.32, 3.94) 0.65 (0.26, 1.61) 0.67 (0.08, 5.41) 0.78 
OR, odds ratio; CI, confidence interval; NTD, neural tube defect 
a One month preceding the estimated date of conception through the end of the third month of pregnancy. 
b Effect measure estimates for all NTDs combined estimated using unconditional logistic regression. 
c
 Effect measure estimates for NTD phenotypes estimated using polytomous logistic regression. 
d
 P-value for Likelihood Ratio test of homogeneity across neural tube defect phenotypes.   
e Covariates include maternal age, race/ethnicity, education, pre-pregnancy BMI, folic acid and smoking.   
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Table 18. Association between maternal occupational exposure during the periconceptional perioda to organic solvents and orofacial 
clefts, National Birth Defects Prevention Study, United States, 1997-2002. 
 
 Any OFC b          Cleft palate c          Cleft lip ± cleft palate c  
Solvent class OR (95%CI)  OR (95%CI) OR (95%CI) pd 
         
 Unadjusted       
Chlorinated 1.11 (0.86, 1.44)  1.02 (0.68, 1.52) 1.16 (0.86, 1.57) 0.57 
Stoddard 1.34 (0.91, 1.96)  1.47 (0.85, 2.54) 1.26 (0.78, 1.99) 0.64 
Aromatic 1.02 (0.63, 1.65)  1.20 (0.61, 2.36) 0.93 (0.51, 1.66) 0.54 
         
 Adjusted for solvent class       
Chlorinated 1.03 (0.76, 1.40)  0.85 (0.52, 1.38) 1.14 (0.80, 1.62) 0.30 
Stoddard 1.35 (0.86, 2.11)  1.63 (0.85, 3.14) 1.22 (0.72, 2.06) 0.45 
Aromatic 0.92 (0.55, 1.52)  1.11 (0.54, 2.29) 0.81 (0.44, 1.51) 0.49 
         
 Adjusted for solvent class and covariatese     
Chlorinated 0.96 (0.70, 1.33)  0.83 (0.50, 1.38) 1.04 (0.72, 1.51) 0.45 
Stoddard 1.25 (0.78, 1.99)  1.45 (0.72, 2.87) 1.15 (0.67, 2.00) 0.59 
Aromatic 0.88 (0.52, 1.49)  1.03 (0.49, 2.20) 0.80 (0.42, 1.51) 0.58 
OR, odds ratio; CI, confidence interval; OFC, orofacial cleft 
a One month preceding the estimated date of conception through the end of the third month of pregnancy. 
b Effect measure estimates for all OFCs combined estimated using unconditional logistic regression. 
c
 Effect measure estimates for OFC phenotypes estimated using polytomous logistic regression. 
d
 P-value for Likelihood Ratio test of homogeneity across OFC phenotypes.   
e Covariates include maternal age, race/ethnicity, education, pre-pregnancy BMI, folic acid and smoking.   
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4.3.4  Discussion 
We observed an increased prevalence of neural tube defects among offspring of 
women exposed to chlorinated solvents during the periconceptional period.  The observed 
association remained after restriction to only isolated cases of NTDs, and after adjusting for 
several potential confounding factors.  Though effect measure estimates were stronger in 
magnitude for encephalocele and spina bifida than for anencephaly, formal homogeneity 
testing did not indicate statistically significant differences in the exposure effect across 
component phenotypes.   
Previous studies with comparable exposure assessment and outcome classification 
have not consistently reported an association between occupational solvent exposure and 
NTDs.  In a California study of occupational risk factors for NTDs, Shaw et al. (1999) found 
no association between organic solvent exposure during the periconceptional period and all 
NTDs combined (0.97 [0.71, 1.3]).95  However, a study of maternal occupation among 
Mexican-American women in Texas found evidence that women with exposure to glycol 
ethers and other solvents were more likely to have an NTD-affected pregnancy.94  To our 
knowledge, our study is the first to investigate maternal occupational exposure to specific 
classes of organic solvents and NTD phenotypes.   
We did not observe a positive association between maternal occupational exposure to 
organic solvents and orofacial clefts.  This finding is not consistent with a number of recent 
studies, all of which have reported large effect estimates for OFC phenotypes and various 
solvent classes including aromatic, chlorinated and petroleum solvents.93,96,98-100   Given that 
all but one of these studies were conducted in France, it is possible that the exposure profiles 
between study populations differed with respect to other parameters (intensity, frequency, 
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etc.) not assessed in this study that are relevant to the potential etiologic relationship between 
solvent exposure and OFC risk.   
We caution against the interpretation of null findings as evidence of no association 
between solvent exposure and OFCs or NTDs, since various sources of bias, such as 
exposure misclassification, could lead to the masking of effects in our study.107  In the 
absence of direct quantitative exposure measurements for each woman from workplace or 
biologic monitoring, our retrospective exposure assessment was limited to estimation of 
exposure status based on published measurements from similar occupations within the same 
industry and era.  Our estimation of exposure therefore was unlikely to capture relevant 
within-job variability related to exposure status as well as other potentially critical factors, 
such as dose and timing.   
Our study was also limited by small sample size, driven primarily by the low 
prevalence of estimated solvent exposure in our study population.  Though our study had 
larger numbers of both NTD and OFC cases than most previous investigations, the results 
from the multivariable logistic models adjusting for multiple potential confounders were 
based on small numbers and often imprecise, especially for encephalocele.  However, effect 
measure sizes in both unadjusted and adjusted analyses were similar for all exposure-defect 
combinations.  A further consequence of small sample size is that if the effect of exposure 
truly varied across NTD or OFC phenotypes, the likelihood ratio tests of homogeneity may 
have been underpowered to detect such heterogeneity.   
The majority of exposed women in our study population were judged to be exposed to 
multiple solvents, and the observed exposure correlation was highest within solvent classes.  
Though correlation in exposure status was expected since mixtures of individual solvents are 
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frequently used in the workplace, the observed correlation was also a function of the 
exposure assessment method.  For example, a number of organic solvents were used for spot 
treatment in dry cleaning operations from 1997 to 2002, making it challenging if not 
impossible to identify the specific solvent(s) to which any given woman with a dry cleaning 
job was exposed.  In such scenarios, the job would be assigned a non-zero probability of 
exposure to all solvent(s) potentially used in that occupation and industry.  Therefore, 
exposure ratings in our study were likely more sensitive than specific, and the observed 
correlation in exposure status was thus high among solvents that were used simultaneously or 
were otherwise mutually prevalent in a given job.  Given this exposure correlation, another 
limitation of our study was that we were unable to examine the potential effect of exposure to 
each of the 10 organic solvents individually.  Grouping solvents by major chemical class 
addressed some of the challenges of within-class correlation.  However, the toxicity of 
solvents is known to vary across individual solvents within class, and analyses by solvent 
class in our study may be biased in an unpredictable direction if exposure effects of 
individual solvents were not additive but rather synergistic or antagonistic.17,19 
In case-control studies with a low prevalence of exposure, suboptimal specificity in 
the exposure assessment despite good sensitivity can lead to substantial attenuation of effect 
estimates.129  We attempted to refine the exposure contrasts in our study and reduce 
misclassification by restricting exposed women in a secondary analysis to those with at least 
one job with an estimated probability of exposure greater than or equal to 10% for any 
individual solvent within each solvent class.  This strategy did not change the observed 
results for Stoddard solvent and aromatic solvents since the vast majority of mothers rated as 
exposed to these solvents had a job with an estimated exposure probability ≥10%.  In 
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contrast, only one third of mothers rated as exposed to chlorinated solvents had a job with an 
estimated exposure probability ≥10%.  The unadjusted OR for chlorinated solvents and 
NTDs in this restricted sample was closer to the null (1.32 vs. 1.85) but also considerably less 
precise given the loss in sample size.  We note that the association we observed between 
chlorinated solvents and NTDs was therefore based on a sample of women with jobs 
generally estimated to have a low probability of exposure.  This might imply that chlorinated 
solvent exposure has a strong effect on NTD risk, though a more likely explanation may be 
that the assigned exposure probabilities based on expected prevalence of exposure to 
chlorinated solvents in a given occupation and industry did not accurately reflect individual 
probability of exposure or another more relevant exposure measure (e.g., peak internal dose) 
in our study population.  
Despite its limitations, our study also has several notable strengths.  The NBDPS is a 
geographically and ethnically diverse population-based study with a relatively large number 
of controls and carefully classified cases, including stillbirths and electively terminated 
pregnancies.  We obtained extensive data from the maternal interview about occupational 
history and potential confounders including maternal age at delivery, race/ethnicity, 
education, pre-pregnancy BMI, and periconceptional folic acid supplement use and smoking.  
The relatively short recall period (on average within 1 year of delivery) minimized the 
potential for recall error in these self-reported data.  Our exposure assessment process 
utilized comprehensive literature-based job-exposure databases to estimate probability of 
exposure to 10 organic solvents for every reported job held during the critical window of 
developmental susceptibility for NTDs and OFCs.  Though resource intensive, this strategy 
avoids recall bias associated with exclusive use of self-reported exposure in case-control 
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studies.  Finally, by restricting eligibility to women who reported having at least one job 
shortly before conception and during pregnancy, we attempted to mitigate residual 
confounding by socio-economic status and other factors related to employment status.   
In summary, we observed a positive association between maternal occupational 
exposure to chlorinated solvents during the periconceptional period and the prevalence of 
NTDs in offspring.  Though not consistently reported in previous epidemiologic studies, this 
finding is biologically plausible given that NTDs may be particularly susceptible to oxidative 
stressors like organic solvents.  Recurring weak associations observed in epidemiologic 
studies of suspected teratogens may reflect true underlying causal mechanisms and merit 
further attention.107  To establish (or refute) causality, future studies should ideally be 
designed to improve upon previous limitations in exposure assessment and outcome 
classification in an effort to produce unbiased estimates.  Additional experimental research is 
also needed to advance our understanding of the possible biologic mechanisms by which 
organic solvents may cause congenital anomalies.  
 CHAPTER 5: DISCUSSION 
The primary purpose of this research was to advance our knowledge about the 
potential relation between maternal occupational exposure to organic solvents during 
pregnancy and the risk of neural tube defects (NTDs) and orofacial clefts (OFCs) in 
offspring.  During the process of evaluating this research question, we also explored the 
prevalence and patterns of maternal employment during pregnancy to evaluate the presence 
of within-woman variability in employment status over the course of pregnancy.  In addition 
to the strengths, limitations and conclusions that were addressed in detail with respect to each 
research objective in preceding chapters, the following chapter highlights key issues 
influencing the results, discusses the broader interpretation of this research, and provides 
recommendations for future work.    
5.1  Summary of findings, strengths and limitations 
5.1.1  Patterns of maternal employment before and during pregnancy 
As more women enter the labor force, there is increased epidemiologic interest in the 
possible effects of employment on adverse pregnancy outcomes.  Given that the timing of 
prenatal exposures during pregnancy frequently determines the nature and magnitude of 
observed effects, variability in the timing of maternal employment and employment-related 
exposures should be considered when investigating whether such exposures are risk factors 
for adverse pregnancy outcomes.  Yet studies of maternal employment during pregnancy 
often obtain only one measure of employment status and assume that employment status (and 
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other related factors of interest, like usual working hours per week) is constant throughout 
pregnancy.  If employment status is not constant, this practice can lead to biased measures of 
association between employment and adverse pregnancy outcomes due to misclassification 
of employment status during the critical window of exposure.  Although there are published 
reports in the literature that examine duration of employment during pregnancy, none to our 
knowledge have examined patterns of employment change to determine, for example, the 
proportion of women who start working during pregnancy. 
In the first manuscript of this dissertation, we report the prevalence and patterns of 
maternal employment before and during pregnancy among mothers who participated as 
controls in the NDBPS between 1997 and 2005.  Consistent with recent Census data, we 
found that 72% of women worked at some point 3 months before and during pregnancy, and 
that approximately 80% of these women worked into their last trimester.  Unique to our 
study, we further examined within-woman patterns of employment status, revealing that 75% 
of employed women were consistently employed in one or more jobs before pregnancy 
through their last trimester, whereas 25% of women changed employment status during 
pregnancy.  Among this latter group of women, twice as many were employed before 
pregnancy and later stopped working (15%) than started working after their pregnancy began 
(~7%).  The observation that employment status is not constant over the course of pregnancy 
for a large proportion of women implies that single measures of employment status may not 
accurately characterize maternal occupational exposure occurring during the biologically 
relevant time window of susceptibility to exposure.  Therefore, we remind investigators to 
use a time-dependent assessment of employment status when possible to reduce exposure 
misclassification.   
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While many studies focus on employment status as the primary “exposure” of 
interest, others focus on job title/occupation or job-related exposure (physical exertion, 
chemical use, etc.).  Our study examined within-woman variability in employment status but 
not in occupation.  Approximately 15% of NBDPS control mothers reported having multiple 
jobs before and during pregnancy,122 and thus an examination of the patterns of job change 
would build on our study and further illustrate the potential for exposure misclassification 
when measures of employment do not correspond to the critical window of exposure.  We 
also recognize that the allocation of women into different patterns of employment likely 
represents a non-random function of demographic, behavioral and obstetric factors associated 
with self-selection into (and out of) employment at different times during pregnancy.  
Though we do not know the reasons why women changed employment status (prescribed bed 
rest, need for more income, no need for more income, etc.), it would be valuable to describe 
heterogeneity in the exposure profiles between working women that have differing patterns 
of employment during pregnancy, as differences in sociodemographic and clinical 
characteristics may have implications for the consideration of residual confounding and 
selection bias.  We intend to explore the possibility of expanding our analysis to examine 
patterns of job change as well as to examine factors associated with initiation and termination 
of employment during pregnancy.   
5.1.2  Maternal occupational exposure to organic solvents during early pregnancy 
and selected congenital anomalies 
In the second manuscript of this dissertation, we investigated the relation between 
maternal occupational exposure to organic solvents during the periconceptional period and 
NTDs and OFCs (corresponding to Specific Aims 2 and 3).  We observed an increased 
prevalence of NTDs among offspring of women estimated to be exposed to chlorinated 
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solvents.  The observed association remained after restriction to only isolated cases of NTDs, 
and after adjusting for several potential confounding factors.  Though odds ratio estimates 
were larger for encephalocele and spina bifida than for anencephaly, formal homogeneity 
testing did not indicate statistically significant differences in the exposure effect across 
specific NTD phenotypes.  We did not observe an association between NTDs and estimated 
exposure to Stoddard or aromatic solvents.  For OFCs, we did not observe a positive 
association with estimated exposure to any solvent class.   
Numerous epidemiologic studies have investigated whether maternal exposure to 
organic solvents is associated with congenital anomalies in offspring.  In general, positive 
associations are frequently but not consistently reported.  Inconsistent findings are likely 
explained by differences and limitations in study population, outcome classification and 
exposure assessment.  Our objective was to improve upon the methods of previous studies in 
several ways.  First, rather than use the etiologically heterogeneous outcome of all major 
malformations combined, we focused exclusively on specific congenital anomalies of 
interest.  Toxicological data suggest that NTDs and OFCs may be particularly susceptible 
during early embryonic development to oxidative stressors like organic solvents.  The precise 
classification of defects by clinical geneticists, an asset of the NBDPS, allowed us to examine 
potential differences in observed effects across multiple distinct phenotypes of both NTDs 
and OFCs using polytomous logistic regression.  Second, we attempted to reduce exposure 
misclassification by using an exposure assessment process that combined expert review of 
detailed self-reported occupational histories with era-specific job-exposure databases 
compiled using published data on direct measurements of occupational solvent exposure in 
various occupations and industries.  Although not as ideal as having individual-level 
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exposure data from biologic or environmental monitoring, this strategy minimized the 
potential for recall bias associated with self-reported exposure, and likely resulted in more 
accurate exposure assignment than by using only job title to infer potential workplace 
exposure to solvents.  Third, we accounted for several potentially confounding factors, such 
as folic acid supplementation and smoking, for which extensive timing-specific data were 
obtained during the maternal interview.  Lastly, a number of advantageous features of the 
NBDPS strengthened our analysis, such as the study population, which consisted of a large, 
population-based sample of demographically diverse mothers of cases and controls delivered 
relatively recently in 8 states across the United States, including cases among fetal deaths and 
terminations.   
Despite the strengths of our analysis, our results must be interpreted cautiously in the 
context of our study’s primary limitation: exposure misclassification.  As previously 
discussed in Section 4.3.4, the exposure assessment was likely sensitive but not highly 
specific, meaning that the women truly exposed to a given solvent were likely to be rated as 
exposed, whereas women who were truly unexposed were less likely to be correctly rated as 
unexposed.  This inaccuracy in assignment of exposure status would have resulted in 
misclassification of truly unexposed women into the exposed group for analysis, which 
generally leads to severe attenuation of effects when the prevalence of exposure is low and 
exposure is dichotomized, as was the situation in our study.  Even if our exposure assessment 
could perfectly distinguish between exposed and unexposed jobs, exposure misclassification 
would still be introduced by within-job and within-woman variability in other exposure 
parameters (timing, frequency, intensity, etc.) not assessed in this study.  The expected 
impact of exposure misclassification in our study is attenuation of the observed effect 
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estimates toward the null, though we cannot know with certainty the degree to which or the 
direction in which our results are biased since there are likely other factors influencing our 
results, such as selection bias related to the overall NBDPS participation rate.  
Given the assumption that our results are influenced by substantial exposure 
misclassification, we do not interpret the “null” results we observed for estimated solvent 
exposure and OFCs to be evidence of no association.  Rather, we admit that our study was 
unable to detect an association if one truly exists.  Yet despite the presumed attenuation of 
effect measure estimates, we consistently observed a moderate association between estimated 
exposure to chlorinated solvents and NTDs, even after adjustment for several potentially 
confounding factors such as race/ethnicity.  This suggests either that the effect of chlorinated 
solvent exposure on NTDs is particularly strong, such that our study was able to detect it, or 
that there’s another unknown source of bias inflating the effect measure estimates.  What this 
source(s) of bias could be is difficult to conceive, as it would have to be specifically affecting 
analyses of NTDs (because we didn’t observe elevated estimates for OFCs) and further, 
analyses of NTDs and chlorinated solvents (because we didn’t observe elevated estimates for 
Stoddard or aromatic solvents).  We believe that the observed association between exposure 
to chlorinated solvents and NTDs – particularly spina bifida and encephalocele – may be 
indicative of an underlying relationship that merits further investigation. 
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5.2  Direction for future research 
Over two decades of epidemiologic research have been devoted to the investigation of 
maternal solvent exposure during pregnancy and the occurrence of various congenital 
anomalies.  Despite advances in study design, exposure assessment and analytic methods 
over the years, findings are collectively summarized as “inconsistent” and the scientific 
community remains uncertain about the true effect of solvent exposure during pregnancy.  
Perhaps we’ve reached the limit of what can be learned about solvents and congenital 
anomalies with the suite of epidemiologic tools currently at our disposal.  There are 
significant challenges encountered when studying this particular exposure and outcome of 
interest: congenital anomalies are rare, the prevalence of occupational exposure is low, the 
critical window of exposure is narrow, exposure assessment is indirect, etc.  Thus, one or 
even 10 additional studies constrained by the same practical limitations will not definitively 
prove – or disprove – that solvent exposure causes birth defects.   
To meaningfully advance our understanding of the relation between occupational 
solvent exposure and the risk of birth defects, future research efforts should focus on three 
major areas:  First, we need validation studies of indirect measures of occupational solvent 
exposure during pregnancy, including probability and intensity, so that data are available for 
sensitivity analyses or correction of misclassification error in larger population-based studies 
that must rely on indirect assessment.  Second, we need further laboratory research to 
determine the specific pathway(s) by which individual solvents exert developmental toxicity, 
which will help to inform population-based investigators about relevant exposure parameters 
such as timing, dose, and genetic susceptibility that may be critical to the etiologic 
relationship between solvent exposure and NTDs or other congenital anomalies.  Lastly, we 
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encourage development of novel exposure biomarkers in media that could be reasonably 
obtained for retrospective epidemiologic studies, like maternal serum or newborn blood 
spots, which would present a distinct opportunity to revisit this research question with an 
independent source of exposure assessment.   
Until we have a better understanding of the potential teratogenic effects of organic 
solvent exposure during pregnancy, it’s reasonable for women to avoid using organic 
solvents or products containing high concentrations of organic solvents, or to take 
precautions to minimize exposure (such as using personal protective equipment) during early 
pregnancy.  Occupational physicians and other health care providers should discuss potential 
exposure to organic solvents with their patients when evaluating other occupational risk 
factors during preconception counseling and early prenatal care.   
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